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ABSTRACT	  	  
 
Strong, Christy, Ph.D., Spring 2011  Integrative Microbiology and Biochemistry 
 
 
Characterization of 5’UTR splicing and the CGI in HIV-2 RNA 
 
Chairperson:  Dr. J. Stephen Lodmell 
 
Co-Chairperson:  Dr. Jean-Marc Lanchy 
 
 
  HIV-2 tightly regulates several steps of its replication cycle via regulatory elements 
found within the 5’ untranslated region of HIV-2 genomic RNA.  Two elements of 
interest are the 5’UTR intron and the proposed long distance base pairing interaction 
between the C-box and G-box termed the CGI.  This research focuses on the effects of 
5’UTR splicing and the CGI in HIV-2 translation and replication.  The central hypothesis 
is that both 5’UTR splicing and the CGI modulate HIV-2 translation and replication.  
This hypothesis was tested and supported by employing in vitro translation assays, 
SELEX, and cell culture studies.  Results of these experiments demonstrate that splicing 
of the 5’UTR intron produces an isoform of gag mRNA that is specialized for high 
translational efficiency.  Further, evidence is provided for a novel branched secondary 
structure within the CGI that is important for HIV-2 replication.  In addition, we show 
that mutation of the C-box alone can enhance RNA encapsidation and mutation of the G-
box can alter levels of Gag protein isoforms.  These studies suggest coordinated 
regulation of RNA translation, dimerization, and encapsidation during HIV-2 replication.  
This research provides new insight into HIV translational mechanisms, in turn identifying 
potential antiviral targets that may be exploited for antiviral therapeutic strategies. 
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CHAPTER	  ONE:	  	  INTRODUCTION	  
1.1	   Acquired	  immunodeficiency	  syndrome	  
Acquired immune deficiency syndrome (AIDS) was first described in June 1981 
(1,2).  Four otherwise healthy homosexual men in Los Angeles, California presented 
with Pneumocystitis carinii pneumonia, a rare opportunistic infection.  Over the next 
year, the number and type of opportunistic infections seen by the United States 
medical community increased significantly (3).  Indeed, the affected pool population 
had now grown to include not only the male homosexual community but also to 
include intravenous drug users, hemophiliacs, as well as specific immigrant 
populations (4-7).  The mortality rate for those afflicted was high, nearing 40% (3) 
and the etiologic agent was unknown. 
The scientific community recognized routes of transmission to include sexual 
contact (genital fluids), blood transfusion and intravenous drug use (blood and blood 
products), as well as mother to child (in utero and via breast milk) (8).  To diagnose 
AIDS, physicians looked for symptoms that included opportunistic infections, 
lymphopenia (low lymphocyte counts), altered T-cell ratios (T4+ helper/T8 
suppressor), prolonged fever, and anergy to skin test antigens (failure to mount a 
response) (3,9).  Alarmingly, a population of healthy homosexual males screened in 
New York City in 1982 displayed altered T-cell ratios, suggesting that physicians 
were just seeing “the tip of the iceberg” with regard to potential AIDS cases (3,10).  
This defined the need to determine and then be able to screen for the causative agent 
of AIDS.   
1.2	   Human	  immunodeficiency	  virus	  
Although the causative agent of AIDS was determined to be a retrovirus in 1983, the 
type of retrovirus was a source of controversy for several years (11-13).   The 
Montagnier laboratory stated they had discovered a unique T-lymphotrophic 
retrovirus associated with AIDS, designated lymphadenopathy associated virus 
(LAV), and demonstrated LAV was cytopathic to CD4 cells (14,15).  Robert Gallo’s 
laboratory suggested that the virus associated with AIDS was in fact human T-cell 
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leukemia virus (HTLV), a member of the Oncornavirus genus and designated it 
HTLV-III (16-18).  Eventually, it was determined that the LAV isolate and the 
HTLV-III isolate were identical (19), and that this unique retrovirus was not a 
member of oncogenic retroviruses comprising the Oncornavirus genus.  The virus 
was then renamed Human Immunodeficiency Virus (HIV) in 1986 (20).  It is notable 
that during this period, a reliable test for the retrovirus was developed (21).  This 
allowed for screening of blood and blood products (22), as well as aided in the 
identification of high-risk asymptomatic HIV-infected individuals (23).  In addition, 
screening with this test confirmed that a disease termed “slim” in Africa, was, in fact, 
AIDS (24).  In addition, a second type of retrovirus (LAV-II) was identified in 
infected African individuals (25,26), which would later be designated HIV-2. 
HIV-1 and HIV-2, retroviruses of the Lentivirus genus, are the causative 
agents of AIDS.  Although, they display similar genomic organization (Figure 1), 
there are significant differences between these viruses.  HIV-1 infection is found 
throughout the world, while HIV-2 infections are primarily concentrated in western 
African countries (27) 
 
Figure 1.  HIV-1 and HIV-2 genomes. 
All nine encoded genes for each virus, HIV-1 and 2, are represented above.  The LTR represents the long 
terminal repeat found at both ends of the genome.  Adapted from (28). 
HIV-2, an often less pathogenic virus, exhibits an overall slower progression to AIDS 
in infected individuals (29,30) in addition to a lower transmission rate compared to 
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HIV-1 (31-33).  The lowered pathogenicity is associated with lower viral RNA levels 
in the plasma of HIV-2 infected patients.  Some have attributed the lower viral RNA 
levels to lower HIV-2 viral DNA levels, however a consensus has not been reached 
on this subject (34-36).  There is a significantly higher proportion of HIV-2 infected 
individuals termed long-term non-progressors than there is in the HIV-1 population 
(29,37).  Long-term non-progressors or elite controllers carry lower viral loads and 
have lower mortality rates than other HIV-infected individuals (37,38).  Indeed, the 
lower pathogenicity displayed by HIV-2 suggests a mechanism of control that 
warrants further investigation into regulation of HIV-2 replication (39)   
	  1.3	   HIV	  replication	  cycle	  
HIV replication begins with the binding of the virus to the cell (Figure 2).  Following 
fusion and entry, the virus uncoats and begins the process of reverse-transcribing the 
vRNA genome into proviral DNA using the viral reverse transcriptase.  The 
completed proviral DNA is transferred into the nucleus where it is integrated into a 
host chromosome.  Once integrated, proviral DNA is transcribed by the host’s RNA 
polymerase II into viral mRNAs. 
 
 
Figure 2. The HIV replication cycle. 
A simplified representation of the HIV replication cycle in an infected cell.  The cycle begins with binding 
(1) and progresses to assembly and budding (8).  Both genomic RNA and mRNA are represented in red.  
Proviral DNA is represented in blue.  Host chromosomal DNA is represented by the black lines in the 
nucleus. 
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Early in infection, multiply-spliced viral RNAs are produced and are exported out of 
the nucleus via host machinery.  These viral RNAs include rev (export protein for 
partially spliced and unspliced viral RNAs), nef (a virulence factor with multiple 
functions), and tat (transactivator of viral transcription) mRNAs (40,41).  Tat proteins 
act as transcription activators through recruitment of positive transcriptional 
elongation factor b (PTEFb) to the TAR (transactivation response region) element 
located at the 5’ end of all HIV RNAs.  This recruitment leads to C-terminal domain 
phosphorylation of the host RNA polymerase II, in turn increasing RNA synthesis.  
As the viral cycle progresses, other classes of viral RNAs are produced including 
partially spliced (vif, vpx, gag, gag-pol) and unspliced species (gag, gag-pol).  These 
RNAs contain a Rev responsive element (RRE), which is recognized by the Rev 
protein (42).  Rev proteins binds to the RRE of these viral RNAs allowing for export 
into the cytoplasm.  Translation initiation of these viral RNAs occurs through 
multiple methods including ribosomal scanning, IRES, and frame-shifting, and results 
in production of various viral proteins including Gag and Gag-Pol (polyprotein 
precursors) (43).  Once enough of these proteins has been synthesized, viral particle 
assembly at the plasma membrane can begin.   
Meanwhile, in the rough ER, the envelope polyprotein precursor (gp140) is 
synthesized and post-translationally modified.  As this precursor transverses the 
Golgi, it undergoes cleavage by a host protease resulting in two mature glycoproteins, 
surface unit gp125 and transmembrane gp36.  These proteins then travel to the cell 
surface where they are incorporated into the viral particles.   
Two copies of the RNA genome are encapsidated as a dimer into each viral 
particle (44).  Dimerization of the genomic RNAs occurs through non-covalent 
intermolecular interactions.  The strongest of these interactions involves a structural 
element located in the 5’UTR region, called stem loop 1 (SL1) or dimerization 
initiation site (45).  Once the genomic RNA dimer is packaged, budding of the virus 
particle occurs, in tandem with activation of the viral protease.  Processing of Gag 
and Gag-Pol by the viral protease (PR) within the virion is necessary for maturation 
and eventual infectivity of the virion.  Cleavage of Pol gives protease (PR), reverse 
transcriptase (RT), and integrase (IN).  Cleavage of the Gag polyprotein gives the 
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matrix (MA), capsid (CA), nucleocapsid (NC), and p6 proteins (40).  To coordinate 
the steps of the replication cycle, HIV relies on interactions between viral and host 
proteins and on regulatory motifs contained within its RNA genome.  The region with 
the highest density of regulatory motifs is the 5’ untranslated region (5’UTR). 
1.4	   The	  5’	  untranslated	  region	  of	  HIV	  
The highly conserved 5’UTR of HIV is packed with identified regulatory elements 
that modulate transcription and translation (TAR), packaging (pal), and genomic 
RNA dimerization (SL1) (46-48).  These signals can be presented or masked at 
different stages of the replication cycle through conformational changes.  Although 
HIV-1 and HIV-2 share overall organization of their 5’UTRs, there are significant 
differences between these retroviruses.  The first major difference between HIV-1 and 
2 is overall nucleotide length of their respective 5’UTRs (Figure 3).  The 5’UTR of 
HIV-1 (LAI isolate) is 335 nt in length while the 5’UTR of HIV-2 (ROD isolate) is 
significantly longer at 545 nt.  The second difference lies within the overall structure 
of TAR.  HIV-1 has a 59 nt TAR structure that contains one major stem loop while 
HIV-2 has 123 nt TAR structure that contains 3 stem loops (49-51). The third 
difference is the presence of an intron in the 5’UTR of HIV-2 but not HIV-1 (52).  
This 5’UTR intron encompasses roughly half of TAR, the entire polyA signal 
domain, and the C-box region. 
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Figure 3.  Schematic of Secondary Structure of HIV 5’ Leaders.   
The HIV-2 ROD leader region and the HIV-1 HxB2 leader region are represented on the left and right, 
respectively.  TAR, polyA signal stem loop, C-box, primer binding site, Ψ, SL1, major SD and the G-box 
represent the transactivation region, the poly(A) signal domain, the core of the C-box, the tRNA primer 
binding site, the packaging signal, Stem loop 1, the major splice donor site, and the core of the G-box.  The 
C-box-G-box interaction for both leader regions is highlighted in red.  The HIV-2 5’UTR intron splice 
donor (nt 61-62) and splice acceptor sites (201-202) are highlighted in black, in addition to the major SD 
(471-472). 
1.5	   Dimerization	  through	  the	  5’UTR	  in	  HIV	  
Each virion contains two genomic RNAs packaged in a dimeric form (44).  The 
genomic RNA dimer is achieved through non-covalent intermolecular interactions 
initiated through the primary dimerization signal of each RNA.  The primary 
dimerization signal, stem loop 1 (SL1), is located in the 5’UTR for both HIV-1 and 
HIV-2.  Elements within the 5’UTR can regulate the presentation of SL1 (Figure 4).  
In HIV-1, a long-range base pairing interaction between two elements, the C-box and 
G-box, is found in a dimerization-competent structure (53).  This dimerization-
competent structure presents SL1 for dimerization (Figure 4A and 4C).  In HIV-2, a 
similar long-range base pairing interaction results in a dimerization-incompetent 
structure (47).  This dimerization-impairied structure masks the SL1 signal in a base 
pairing interaction with the packaging signal, ψ (Figure 4B and 4D). 
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Figure 4.  Dimerization-competent and incompetent RNAs. 
A) A schematic of the HIV-1 leader region with a portion of the Gag coding region included.  The HIV-1 
CGI is represented on the top right panel.  B) A schematic of the HIV-2 leader region with a portion of the 
Gag coding region included.  The HIV-2 CGI is represented on the middle right panel.  C) An illustration of 
the C-box, G-box, and SL1 in a HIV-1 dimerization competent conformation.  D) An illustration of the C-
box, G-box, and SL1 in HIV-1 and HIV-2 dimerization-impaired conformations.  Adapted from (54). 
1.6	   The	  C-­‐box	  and	  G-­‐box	  of	  HIV	  
1.6.1	   The	  C-­‐box	  and	  the	  G-­‐box	  
The C-box is a pyrimidine-rich regulatory element whose core encompasses 
nucleotides 189-196 of the 5’UTR (47,55).  Studies have shown that the C-box 
affects both HIV-1 and HIV-2 RNA dimerization (association of two genomic RNAs) 
through a proposed long-range base pairing interaction (CGI) with a downstream 
element termed the G-box (47,53,55,56) (Figure 3).  The G-box is a regulatory 
element that encompasses the Kozak sequence and start codon of Gag, in addition to 
the myristoylation signal coded in gag/gag-pol.  The purine-rich G-box has many 
roles, one of which is the proposed CGI with the C-box. 
1.6.2	   The	  CGI	  in	  HIV	  
The 5’ leader regions of both HIV-1 and -2 have been proposed to form two alternate 
conformations, the branched multiple hairpin form (BMH) and the long distance 
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interaction (LDI) form (57,58).  Transitioning between the two conformations has 
been suggested to act as a riboswitch, regulating dimerization of the genomic HIV 
RNAs (53,57,59).  The approximate location of the nucleotides involved in a long- 
range base pairing interaction within the LDI HIV-2 conformer (dimerization-
incompetent form) was initially only inferred (58).  However, a closer examination of 
the 5’ leader using in vitro truncation and mutation studies revealed the identities of 
the two base pairing partners (47). 
The C-box, whose core encompasses nucleotides 189-196, and the G-box, 
whose core encompasses nucleotides 543-550, were shown to inhibit dimerization 
through a long-range base pairing interaction that we now call CGI.  Inhibition of 
HIV-2 RNA dimerization was suggested to occur through structural entrapment of the 
major dimerization site (stem loop one; SL1) by the CGI (54,60).  Addition of 
nucleocapsid protein (NC) to dimerization reactions was shown to relieve this 
inhibition (47).  Interestingly, formation of the CGI in HIV-1 may not be detrimental 
to dimerization (53,61,62).  In fact, the HIV-1 CGI formation is associated with the 
dimerization-competent BMH conformation.   
Although the long-range base pairing interaction (HIV-2 CGI or HIV-1 U5-
AUG duplex) differs with respect to its regulation of HIV-1 and -2 dimerization, its 
possible role in modulation of gag translation was proposed to be similar (47,60,61).  
Because the CGI encompasses the gag translation initiation site, the formation of the 
CGI was postulated to influence Gag protein synthesis.  An initial study in HIV-1 
suggested that a leader RNA conformation that was supposed to occlude the start 
codon through base pairing did not affect translation, but the study did not directly 
probe the role of the G-box and C-box sequences when examining steady-state levels 
of Gag (53).  At the same time, an examination of the role of the CGI in HIV-2 
translation had not been undertaken, and the question of translational control through 
the CGI in HIV-1 or HIV-2 had not been unequivocally answered. 
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1.7	   Translation	  
1.7.1	   General	  
In order to understand the effects of 5’UTR splicing and the CGI in HIV-2 
translation, an understanding of the basic mechanism of translation is needed.  
Eukaryotic translation of mRNA to protein is a multi-step process involving a variety 
of initiation and elongation factors that assist with progression of the cycle.  The four 
mains steps of translation are initiation, elongation, termination, and ribosome 
recycling.  To prepare for translation and generate free 40S ribosomes, recycling of 
inactive 80S ribosomes is necessary (Figure 5).  To that end, select eIFs bind to the 
40S subunit, causing dissociation from the 60S, yielding a small ribosomal subunit 
pool.  Additional eIFs join the complex including eIF5 and the ternary complex 
consisting of eIF2-GTP bound to an initiating Met-tRNAi (63,64). 
 
Figure 5.  Preparing the ribosomal pool. 
The 40S subunit pool is obtained from 80S inactive ribosome complexes.  eIF1, 1A and 3 bind to the 40S 
resulting in its disassociation from the 60S subunit.  eIF5 binds to the 40S as well as the ternary complex 
composed of eIF2-GTP bound to the Met-tRNAi.  Binding of all components results in the formation of the 
43S ribosome.  Adapted from (63).   
Meanwhile, the mRNA to be translated undergoes activation (Figure 6) (64).  This 
involves interaction of the mRNA with eIF4F.  Once activated, the mRNA is now 
ready to bind to the 43S. 
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Figure 6.  mRNA activation and formation of the 48S compex. 
mRNA is activated through the binding of eIF4F.  Once bound, secondary structure of the 5’ end is 
removed by the RNA helicase activity of eIF4A.  The bound mRNA is now ready to join with the 43S, via 
interactions between eIF4G and eIF3, to form the 48S compex.  Adapted from (63). 
Once the 48S complex is formed, the ribosome begins scanning along the mRNA in 
the 3’direction until an initiation AUG codon is reached (Figure 7).  Once the 
initiating AUG codon is recognized, eIF2-GDP is released along with eIF1.  The 
association of the 60S subunit follows leading to formation of the 80S ribosome.  
Translational elongation can now proceed, followed eventually by translational 
termination when a stop codon is encountered (63,64). 
 
Figure 7. Formation of the 80S ribosome. 
The 48S ribosome scans the mRNA in a 3’ direction.  Once an initiating AUG codon is recognized, eIF2-
GDP is released while eIF5B-GTP is bound. Binding of the 60S subunit occurs followed by eventual 
formation of the 80S ribosome.  The 80S ribosome is now ready to perform translational elongation. 
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1.7.2	   Regulators	  of	  translational	  initiation	  
Regulation of protein synthesis is an essential component of the overall regulation of 
gene expression.  Translational control is largely exerted at the level of translation 
initiation.  Translation initiation is strongly influenced by the features of the mRNA 
to be translated.  These include the 5’ methyl7 G-cap, 5’ leader secondary structure 
and length, splicing, polyadenylation, eIF state, the Kozak consensus sequence of the 
initiating codon, and upstream 5’UTR open reading frames (uORFs).   
The presence and accessibility of the 5’methyl7G-cap is not an absolute 
requirement but has been shown to stimulate translation through recruitment of eIF4E 
and eIF4G (65).  Binding of eIF4G allows for the associated helicase-activity of 
eIF4A, which reduces secondary structure of the 5’ leader. 
The length and overall secondary structure of the 5’ leader has been shown to 
directly influence translational initiation.  The closer the secondary structure is found 
to the 5’end of the mRNA, the more chance it has to inhibit ribosome entry (66,67).  
Additionally, increased secondary structure can impede a scanning ribosome, due to 
limits of the ribosome’s ability to disrupt base pairing structures (68).  One method 
for physically reducing the amount of secondary structure is by removal of RNA 
sequence through splicing. 
Splicing out of introns in pre-mRNA removes length and secondary structure, 
in essence, truncating the 5’ leader, which leads to enhanced translational initation 
(69,70).  In addition, splicing allows for export of mRNAs out of the nucleus and into 
the cytoplasm, where the translational machinery is found (71).  Once in the 
cytoplasm, spliced mRNAs display an enhanced ability to interact with ribosomes, 
which may be attributed to the presence of exon junction complexes (EJCs) on the 
mRNA (71,72).  Exon junction complex proteins are placed upstream of exon-exon 
junctions following splicing, and play a role in detection of defective mRNAs in 
nonsense mediated decay (73).  Another checkpoint for mRNA quality involves 
polyadenylation of the mRNA. 
Improper polyadenylation of pre-mRNA can result in immediate targeting for 
degradation within the nucleus (71,74).  In addition, polyadenylation has been 
suggested to influence translational initiation in the cytoplasm through the interaction 
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of the polyadenylated mRNA tail with polyA binding protein (PABP).  Binding of 
PABP to the polyA tail allows for circularization of the RNA via eventual binding of 
PABP to eIF4G (75,76), leading to enhanced cooperation amongst the translational 
machinery components. 
Altering the phosphorylation states of eIFs can have negative consequences 
for translational initiation.  Phosphorylation of eIFs can prevent these factors from 
engaging with the translational machinery (64).  Phosphorylation of eIF2α induces 
binding to eIF2B, which prevents eIF2α recycling, while phosphorylation of eIF4E 
induces binding to eIF4E binding proteins, preventing association of eIF4E with 
eIF4F (64).  While the role of eIFs in translational initiation is important, the context 
of the initiating methionine codon within the mRNA is crucial to translational 
initiation. 
An initiation codon can be part of an upstream open reading frame (uORF), 
which is composed of an AUG, coding sequence, and a termination codon (77).  
uORFs are found in the 5’UTR and have been shown to modulate initiation at 
downstream initiation codon.  This modulation primarily occurs through two 
mechanisms (77).  The first is by allowing ribosomes to scan through the uORF, a 
process termed leaky scanning.  The second is by initiating translation at the uORF, 
and then reloading the post-termination ribosome to allow initiation at a downstream 
initiation site, a process termed reinitiation.  Both mechanisms can be regulated to 
increase or decrease protein production.  The leaky scanning mechanism is dependent 
on the Kozak sequence context of an initiating methionine codon. 
The Kozak sequence encompasses nucleotides found immediately upstream 
(nts -6 to -1) and downstream (nt + 4) of the initiating methionine codon (A of AUG 
is + 1) (Table 1).  Mutations within the Kozak sequence have been shown to modulate 
translation, with the identity of nucleotides at positions -3, -1, and + 4 drastically 
affecting translational initiation (78,79).  The presence of a purine nucleotide (A 
preferred over G) at position -3 results in a 10-fold increase in translational efficiency 
compared to a sequence containing a pyrimidine nucleotide (78).  Indeed, a poor 
Kozak context can result in leaky scanning whereby the ribosome scans past the first 
initiating methionine to a downstream initiating methionine with a stronger Kozak 
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sequence (80).  This can result in truncated forms of a protein that differ from the 
full-length protein at the N-terminus.  However, leaky scanning is not the only 
initiation method that results in truncated protein isoforms. 
Table 1.  The Kozak sequence. 
Sequences obtained from 699 vertebrate mRNAs were compiled and then analyzed for nucleotide 
composition immediately upstream and downstream of the initiating AUG.  Frequency of each nucleotide at 
each position is represented in percentage.  Arrows indicate those nucleotides that have the largest influence 
on translational initiation within the Kozak sequence.  Nucelotides at position -3 and +4 have the strongest 
effects.  Adapted from (81). 
 
1.7.3	   Types	  of	  translational	  initiation	  
Two main types of translation initiation have been identified in eukaryotes.  
Recognition of the 5’methyl7G-cap is necessary for one type of initiation but not the 
other.  Cap-dependent initiation is the predominant mode of translational initiation in 
the eukaryotic cell.  The 43S ribosome recognizes the bound 5’methyl7G-cap via 
interactions between eIF4G/eIF4B and eIF3/eIF5.   Binding to the 5’ end of the 
mRNA occurs, allowing the 48S to scan through the 5’UTR in a 3’ direction.  Upon 
recognition of the initiation AUG codon, the 48S ribosome can then proceed to form 
the 80S complex and begin actively translating the mRNA.  In contrast, internal 
ribosome entry site (IRES) translational initiation does not require the presence of the 
5’-methyl7G-cap, instead the IRES directly recruits the translational machinery via 
secondary structures formed by the mRNA.   
IRES translational initiation was first identified in the polio virus (82).  The 
5’UTR of the polio viral RNA is long, highly structured, and lacks a canonical 5’ cap 
(83,84).  Based on these characteristics, cap-dependent translation of polio RNA 
would be predicted to be poor.  In addition, polio protease activity shuts down cap-
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dependent host cell translation (85).  Therefore, polio was hypothesized to initiate 
translation through a cap-independent mechanism.  Studies determined that a 
sequence contained within the polio 5’UTR was sufficient for internal translational 
initiation.  This sequence, when fused to other mRNAs, could confer IRES activity to 
those normally cap-dependent mRNAs (82).  Once IRES activity was identified in 
polio, identification of IRES activity in other viruses soon followed (86).  Among the 
identified viral IRESes, it was shown that the number of initiation factors needed to 
recruit the 40S ribosome varies (Figure 8) (87).  Examples range from the highly 
structured Cricket paralysis virus (requiring only the 40S ribosome) (88) to the less 
structured foot and mouth disease virus (FMDV), which requires all of the initiation 
factors with the exception of eIF4E (87,89). 
 
Figure 8.  Types of IRES. 
Three main groups of IRESes are presented above.  The groups are defined by the initiation factors that are 
not needed for translational initiation.  Viruses belonging to each group are listed, as are examples of each 
type of virus.  Those initiation factors not needed are to the left of each IRES structure.  A) IRESes that 
require all initiation factors except eIF4E and eIF4G.  B) IRESes that require all initiation factors except 
eIF4E, eIF4G, and eIF4A.  C) IRESes that require no initiation factors.  Adapted from (86). 
Two groups have independently proposed that HIV-1 contains an IRES.  The 
Siliciano laboratory proposed that HIV-1 contains an IRES within the Gag coding 
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region (Figure 9) (90).  Translation initiation using this IRES can produce either a 
full-length Gag protein (with backscanning to the initiating AUG) or a truncated Gag 
protein.  The Sonenberg laboratory proposed that HIV-1 contains an IRES within the 
5’UTR (91).  Translation initiation using this IRES could produce the full-length Gag 
protein.  However, a consensus has not been reached with regard to the presence of an 
IRES in HIV-1 (92).  
 
Figure 9.  Retrovirus IRESes located in the Gag coding region. 
A schematic of IRES structures for HIV-1, SIVmac, and HIV-2, respectively.  The IRESes represented above 
are encompassed entirely within the Gag coding region for each virus.  Shared structures are shown in light 
grey boxes.  Adapted from (93). 
Although an IRES has been proposed to occur in both the 5’UTR and the Gag 
coding region (Figure 9) of the closely related SIVmac239 (94,95), a 5’UTR IRES has 
not been proposed to occur in HIV-2.  HIV-2 has been suggested to contain an IRES 
located downstream of the gag initiation codon (96), formed entirely from nucleotides 
within the gag open reading frame (Figure 9).  According to this model, three 
isoforms of Gag are attributed to HIV-2 IRES activity, with translation initiation able 
to occur at three distinct methionine codons (97).  The HIV-2 IRES is proposed to 
comprise three distinct and independent segments that direct translational initiation at 
each of the respective methionine start codons (98).  In addition, Weill et al. have 
suggested that the HIV-2 IRES is capable of recruiting three initiation complexes 
onto the same RNA, one positioned at each of the respective initiating methionine 
(99).  This ability would put the HIV-2 IRES in a class of its own. 
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1.7.4	   HIV	  translation	  
Numerous mechanisms for modulating translation of HIV mRNAs have been 
proposed.  Some have been mentioned above, including secondary structure at the 5’ 
end (48,100), splicing (52), and IRES (43,91,96).  Others are more specific to HIV 
replication, including the actions of TAR, Rev, and Protease. 
 Because of HIV-2 TAR’s significant secondary structure and location, a role 
in modulation of translation was obvious.  However, TAR also modulates translation 
by another means, through activation of PKR (101).  PKR, a double stranded RNA 
dependent kinase, when activated will phosphorylate eIF2α, preventing recycling of 
this elongation factor.  Interestingly, HIV circumvents this self-induced inhibition 
through competitive binding of PKR by the HIV Tat protein, thus inhibiting 
phosphorylation of eIF2α (102).  This is not the only HIV protein that modulates 
translation 
 The Rev protein also plays a critical role in translation, primarily through its 
interaction with unspliced and incompletely spliced HIV mRNAs.  In eukaryotic 
cells, unspliced and incompletely spliced mRNAs are not efficiently exported out of 
the nucleus.  HIV evades this quality control step through the actions of Rev.  Rev 
proteins enter the nucleus and bind to and coat mRNAs containing the Rev responsive 
element (RRE).  This coating allows for the export of HIV unspliced and 
incompletely spliced mRNAs out of nucleus and into the cytoplasm.  Moreover, 
association of the Rev protein with the HIV mRNAs has been shown to increase the 
association of the mRNAs with polyribosomes, in turn modulating translation (103). 
HIV protease is another viral protein that can regulate HIV translation by 
cleaving eIF4G (104) and PABP (105) .  Removal of functional eIF4G from the 
initiation factor pool prevents recognition of the 5’methyl7G-cap and therefore 
activation of mRNA.  Cleavage of PABP prevents its association with the polyA tail 
of mRNAs as well as its interaction with initiation factors.  Consequently, HIV 
protease activity leads to down-regulation of cap-dependent translation initiation and 
up-regulation of cap-independent IRES initiation. 
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1.8	   Hypotheses	  
TAR (transcription and translation), pal (packaging), the C-box (dimerization) and the 
G-box (dimerization) all play roles in regulation of HIV-2 replication.  As illustrated 
above, a regulator may exert influence during more than one step in the replication 
cycle.  We propose that this is also the case for the CGI. We have previously shown 
that the CGI regulates in vitro dimerization.  Based on the composition of the G-box 
(Kozak sequence and initiation codon of gag), the formation or disruption of the CGI 
may also influence Gag synthesis.  In conjunction, the position of the C-box within 
the 5’UTR may play a role in Gag regulation.  The C-box is contained within the 
5’UTR intron.  If the 5’UTR intron were spliced out of a gag RNA, the C-box, the 
polyA signal domain, and half of TAR would be removed.  Indeed, secondary 
structure and length would be reduced in tandem with the disruption of the CGI. 
Therefore, a gag mRNA undergoing 5’UTR splicing should have an improved 5’UTR 
with regard to ribosomal scanning.  To that end, this study focuses on the roles of the 
5’UTR intron and the proposed long distance base pairing interaction (CGI) between 
the C-box and the G-box.   
The overall hypotheses for this research are: 1) A 5’UTR-spliced gag mRNA 
isoform exists, specialized for producing Gag protein and 2) Maintaining the ability 
to form a proposed CGI between the C-box and G-box is critical for one or more 
steps of HIV-2 replication.  This study employs biochemical, molecular, and cell 
culture techniques to test these hypotheses.  I have identified functional roles and 
requirements of the 5’UTR intron and the proposed CGI, providing further insight 
into how to target various steps of the HIV-replication cycle.  Previous research on 
HIV-2 5’UTR splicing neglected to address its effect on gag mRNA.  Our studies 
have remedied this omission.  In addition, our studies on the proposed CGI have 
finally put to rest whether or not this proposed interaction occurs in HIV-2 RNA. 
 
1.8.1	   Specific	  Aim	  1.	  Characterize	  the	  role	  of	  5’UTR	  splicing	  in	  Gag	  production.	  
HIV RNAs are grouped into three classes based on alternative splicing (40,106,107).  
The first class consists of multiply spliced HIV RNAs including tat, rev, and nef.  The 
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second class consists of partially spliced HIV RNAs including env, vif, vpu, and vpr.  
The third class consists of unspliced HIV RNAs including gag and gag-pol.  
Alternative splicing in HIV-1 occurs in a sequential manner, where the most 5’ intron 
is removed first (108).  The splice donor site of the most 5’ intron in HIV-1 is the 
major splice donor site (SD).  The major SD is located at the end of the 5’UTR.  Like 
HIV-1, HIV-2’s major splice donor site is also located at the end of the 5’UTR.  
However, unlike HIV-1, HIV-2 contains an intron upstream of the major SD.  The 
5’UTR intron is contained entirely within the 5’UTR.  The location of the 5’UTR 
intron suggest that is possible to have a splicing event and still retain the entire gag 
and gag-pol reading frame.  In essence, having 5’UTR spliced and 5’UTR unspliced 
gag and gag-pol RNA isoforms is possible in HIV-2.  5’UTR splicing of gag and 
gag-pol does occur in SIVmac239, a closely related retrovirus (109).  The spliced leader 
of SIVmac239 gag/gag-pol mRNAs display enhanced translational efficiency compared 
to the unspliced leader (109).  Whether this is applicable in HIV-2 is not known. 
I hypothesized that 5’UTR splicing of gag/gag-pol mRNA occurs during 
HIV-2 infection.  Removal of the 5’UTR should increase translational efficiency, 
producing more Gag from the 5’UTR spliced isoform than its unspliced counterpart. 
This hypothesis was tested by comparing translation of 5’UTR unspliced and 5’UTR 
intronless constructs in cell culture and translation experiments. 
 
1.8.2	   Specific	  Aim	  2.	  Characterize	  the	  sequence	  and/or	  base	  pairing	  requirements	  
of	  the	  C-­‐box	  and	  G-­‐box.	  
The requirement of the presence of both the C-box and G-box RNA motifs to 
modulate RNA dimerization in vitro, in HIV-2, suggested that a long distance base 
pairing interaction (CGI) occurs between the two motifs during viral replication.  I 
hypothesized that the sequence requirements of both motifs are dependent on their 
ability to form a long distance base pairing interaction (CGI) with their respective 
partner.  I tested this hypothesis by randomizing the C-box and G-box motifs using a 
modified SELEX (Systematic Evolution of Ligands through Exponential Enrichment) 
technique to produce randomized libraries of proviral DNAs.  These libraries were 
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used in cell culture experiments to determine sequence and/or base pairing 
requirements. 
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2.1	   Abstract	  
Full-length unspliced genomic RNA plays critical roles in HIV replication, serving 
both as mRNA for synthesis of the key viral polyproteins Gag and Gag-Pol and as 
genomic RNA for encapsidation into assembling viral particles.  We show that a 
second gag mRNA species that differs from the genomic RNA molecule by the 
absence of an intron in the 5’ untranslated region (5’UTR) is produced during HIV-2 
replication in cell culture and in infected patients.  We developed a cotransfection 
system in which epitopically tagged Gag proteins can be traced back to their mRNA 
origins in the translation pool.  We show that a disproportionate amount of Gag is 
translated from 5’UTR intron-spliced mRNAs, demonstrating a role for the 5’UTR 
intron in the regulation of gag translation.  To further characterize the effects of the 
HIV-2 5’UTR on translation, we fused wild type, spliced, or mutant leader RNA 
constructs to a luciferase reporter gene and assayed their translation in reticulocyte 
lysates.  These assays confirmed that leaders lacking the 5’UTR intron increased 
translational efficiency compared to that of the unspliced leader.  In addition, we 
found that removal or mutagenesis of the C-box, a pyrimidine-rich sequence located 
in the 5’UTR intron and previously shown to affect RNA dimerization, also strongly 
influenced translational efficiency.  These results suggest that the splicing of both the 
5’UTR intron and the C-box element have key roles in regulation of HIV-2 gag 
translation in vitro and in vivo. 
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2.2	   Introduction	  
Unspliced genomic-length RNA plays at least two central roles in HIV replication.  It 
serves both as messenger RNA for the synthesis of the key viral proteins Gag and 
Gag-Pol and as genomic RNA for encapsidation into virus particles.  Regulation of 
the use of this full-length viral RNA as either mRNA or genomic RNA (or both) is 
likely to be critical for efficient viral replication.  In fact, regulation of many viral 
RNA functions, including translation and encapsidation, occurs through the 5’ 
untranslated region (UTR), a highly conserved region in human immunodeficiency 
virus (HIV) (46). 
Previous research has shown that the 5’UTR influences translation of HIV-1 
mRNAs.  The overall length of the HIV-1 5’UTR was shown to contribute to a 
decrease in initiation efficiency by increasing the requirement for ribosomal scanning 
in advance of the AUG start codon (110).  In addition, the position and stability of the 
highly structured transactivation responsive element (TAR) at the very 5’ end of the 
UTR plays a role in impeding 5’ cap accessibility and ribosomal scanning (48).   
HIV-2 and HIV-1 share a common overall organization of their 5’UTRs; thus, 
it is likely that HIV-2 mRNA translation is influenced by the 5’UTR.  However, 
differences between the HIV-1 and HIV-2 UTRs may necessitate alternative modes 
of translational regulation.  First, the HIV-1 (LAI isolate) leader region is 
significantly shorter at 335 nucleotides (nt) long compared to the HIV-2 (ROD 
isolate) leader region, which is 545 nt long.  Second, HIV-1 contains a 59-nt TAR 
structure consisting of one major stem-loop, while HIV-2 contains a larger 123-nt 
TAR structure consisting of three stem-loops (49-51).  Third, unlike HIV-1, the HIV-
2 5’UTR contains a predicted intron (52).  Splicing of this intron results in the 
removal of 140 nucleotides of 5’ leader sequence including half of the large TAR 
structure sequence, the entire poly (A) signal domain, and the C-box region (Figure 
10; compare A to B).   
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Figure 10.  Schematic of the two forms of HIV-2 gag (and gag-pol) mRNAs.   
The two forms are 5’UTR-unspliced (A) and 5’UTR-spliced (B), respectively.  TAR, poly(A) signal, C-box, 
PBS, major SD, G-box, gag, and pol represent the transactivation region, the poly(A) signal domain, the 
core of the C-box, the tRNA primer binding site, the major SD site, the core of the G-box, the Gag protein 
coding region, and the Pol protein coding region, respectively.  
 
Evidence of 5’TR intron splicing was first revealed in a simian immunodeficiency 
virus (SIVmac239), a phylogenetic relative of HIV-2 (111).  Most viral mRNA species 
found in SIVmac239 infected cells were present in both the 5’UTR intron spliced and 
the unspliced forms (109,111).  In HIV-2, evidence of 5’UTR splicing was revealed 
in multiply spliced mRNA species, but its occurrence in gag/gag-pol coding mRNA 
species was not investigated (52). 
 The effects of 5’UTR intron presence or absence on translation were first 
studied using partial leader SIVmac239 constructs truncated at the major splice donor 
(SD) site, thus mimicking the 5’UTR of multiply spliced mRNA species (109).  
Translation of a downstream reporter gene was found to be more efficient if the 
5’UTR intron was not present (109).  However, a direct examination of the role of the 
HIV-2 5’UTR and its splicing in gag (and gag-pol) translational regulation has not 
been conducted and is of unique interest for several reasons.  First, the 5’UTR spliced 
gag is singly rather than multiply spliced at a site that does not employ the otherwise 
ubiquitous major SD site.  Second, it is plausible the 5’UTR splicing could regulate 
translation by shortening and removing secondary structure in the 5’UTR.  Finally, 
this splicing event could regulate translation by removal of RNA signals that have 
importance in other regulatory events, including the long-range interaction between 
the 5’UTR element known as the C-box and the G-box that overlaps the gag 
translation initiation codon (47,58).   
 In this study, we demonstrate the presence of both 5’UTR spliced and 
unspliced gag mRNA species in transfected and infected cells and in peripheral blood 
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mononuclear cells (PBMCs) isolated from HIV-2 infected patients.  We show in 
transfected cells that a 5’UTR unspliced construct yielded less Gag compared to its 
5’UTR spliced counterpart.  To further characterize the effect of the HIV-2 5’UTR on 
translation, we tested the translation of a luciferase reporter gene fused to various 
5’UTR leader constructs in reticulocyte lysates.  We find that leaders lacking the 
5’UTR intron increased translational efficiency compared to constructs harboring the 
unspliced leader.  Furthermore, our in vitro and cell culture studies implicate the C-
box, which is part of the intronic sequence removed by 5’UTR splicing, as a 
contributor to translational regulation.   Taken together, our results underscore the 
importance of the 5’UTR in the coordinated regulation of several essential viral 
replicative functions in vitro and in vivo. 
2.3	   MATERIALS	  AND	  METHODS	  
2.3.1	   Plasmid	  construction	  
To engineer mutations in the 5’ untranslated region or to insert a tag in the C-terminal 
domain of the Gag protein, we used plasmids derived from the modified pROD10 
containing the full-length HIV-2 ROD (112-114).  The 12,828-bp-long modified 
plamsid pROD10 was provided by the EU Programme EVA/MRC Centralised 
Facility for AIDS Reagents, NIBSC, UK  (Grant Number QLK2-CT-1999-00609 and 
GP828102).  The AatII-XhoI fragment of modified pROD10 digestion was subcloned 
in pGEM-7Zf+ (Promega).  This plasmid, pGRAXS, contains the upstream long 
terminal repeat (LTR) and most of the Gag coding region, up to the XhoI site (115).  
The numbering is based on the sequence of the HIV-2 ROD isolate (GenBank no. 
M15390), which is contained with modified pROD10.  Mutations were introduced in 
pGRAXS using either a ligation-PCR protocol (to delete the 5’UTR intron, 
nucleotides 61-202) or the QuikChange II XL site-directed mutagenesis kit 
(Stratagene) and the appropriate primers (to mutate the 5’UTR SD site in the TAR 
structure or the C-box).  The 5’UTR SD(-) mutations removes the SD site while 
keeping the second TAR stem structure intact (nucleotides 61-62 GG changed to CC 
and nucleotides 78-79 CC changed to GG).  The AatII-XhoI fragment of plasmids 
bearing the mutations was then reinserted in the modified pROD10 backbone. 
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To introduce the same mutation [5’UTR SD(-)] in both LTRs, the mutation 
was separately introduced in the unique upstream LTR of pGRAXS as described 
above and in the unique downstream LTR of the pAVR plamsid using the 
QuikChange II XL kit.  The pAVR plasmid corresponds to modified pROD10 
missing an internal AvrII-AvrII fragment encompassing the upstream LTR and gag 
region and thus contains only the downstream LTR.  After mutagenesis, the AvrII-
AvrII fragment containing the mutated downstream LTR in a pGRAXS backbone 
was reinserted in the AvrII site of pAVR mutated in the upstream LTR.  To insert the 
FLAG-tag coding sequence (5’-gat tac aag gac gac gac gac aag-3’, N-terminus-Asp-
Tyr-Lys-Asp-Asp-Asp-Asp-Lys-C-terminus) near the end and in frame with the gag 
gene, we used a single PCR step followed by replacement of the FLAG-tag-
containing XhoI-Bsu361 fragment in wild type and mutated HIV-2 plasmids.  All 
constructs were checked by DNA sequencing. 
2.3.2	   Cell	  culture	  and	  transfection	  
COS-7 cells ere maintained in Dulbecco’s modified Eagle’s (DMEM) medium 
supplemented with 10% fetal calf serum, penicillin, and streptomycin (Invitrogen).  
Transient transfection of COS-7 cells was performed using Trans-IT-COS 
transfection kit (Mirus).  Cells and media were harvested two days posttransfection.  
HIV-2 capsid protein levels in the media were quantified by a p27 ELISA (SIV p27 
ELISA; Zeptometrix). 
2.3.3	   Cell	  culture	  and	  infection	  
C8166 cells (116) were maintained in Roswell Park Memorial Institute (RPMI) 1640 
medium supplemented with 10% fetal calf serum, penicillin, streptomycin, and 
glutamine (Invitrogen).  Media from transfected COS-7 cells containing 10 ng of 
HIV-2 p27 capsid protein, as determined by ELISA, was used to infect 2 x 104 C8166 
cells (NIH AIDS reagent, no. 4040).  After 12 hours, cells were washed twice and 
resuspended in RPMI/fetal bovine serum.  A media aliquot was then taken and served 
as a reference (ELISA p27).  Aliquots of media were taken daily, spun to remove 
cells, and the supernatant frozen at -80˚C.  The viral replication was followed for one 
or two weeks by quantifying the level of Cap27 protein in the supernatant.  The 
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Cap27 protein concentration was determined by ELISA (Retro-Tek SIV p27 Antigen 
ELISA kit from Zeptometrix). 
2.3.4	   Protein	  isolation	  and	  analysis	  
Intracellular COS-7 RNA and proteins were harvested 48 hours after transfection by 
washing and scraping cells in phosphate-buffered saline.  To prevent Gag cleavages, 
an HIV protease inhibitor, saquinavir, was added to the media of the transfected cells 
24 hours before harvesting (10 µM final concentration).  One half of the cells was 
harvested in RNA lysis buffer for genomic RNA quantitation (see below), while the 
other half was lysed in radioimmunoprecipitation assay buffer (Santa Cruz 
Biotechnology Inc.; Tris-HCl, 50 mM, pH 7.4, 150 mM NaCl, 0.1% SDS, 1% 
Nonidet P-40, 0.5% sodium deoxycholate with protease inhibitors).  After lysis on 
ice, cells were passaged six times through a 27-gauge needle, centrifuged for 10 
minutes at 21,000 g and 4˚C, and supernatants were transferred to new tubes.  
Samples were fractionated on SDS-8% polyacrylamide gels.  After electrotransfer 
onto polyvinylidene difluoride (PVDF) membranes, Gag proteins were visualized by 
Western blotting with one of the following primary antibodies:  biotin-labeled anti-
capsid antibody (p27 ELISA kit from Zeptometrix) or goat anti-FLAG tag antibody 
(sc-807G from Santa Cruz Biotechnology).  Bound primary antibodies were detected 
using either streptavidin-horseradish peroxidase (p27 ELISA kit from Zeptometrix) or 
chicken anti-goat IgG-horseradish peroxidase (sc2953 from Santa Cruz 
Biotechnology) by electrochemiluminescence (ECL Plus Western Blotting Detection 
Reagents from GE Healthcare) on a Fujifilm LAS-3000. 
For virion fractions, medium from transfected or infected cells was carefully 
removed without disturbing the cell layer, filtered through 0.45 µm filters to remove 
cells and debris, and centrifuged at 21,000 g for 2 hours at 4˚C to pellet virus.  The 
pellet was gently washed and resuspended in radioimmunoprecipitation buffer.  
Aliquots were then treated as above for electrophoresis, blotting, and visualization. 
2.3.5	   PBMC	  sample	  acquisition	  
The PBMCs of HIV-2-infected individuals were obtained from a cohort of 
commercial sex workers in Senegal that has been followed since 1985.  Detailed 
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clinical and epidemiological data concerning this cohort have been published 
elsewhere (32,117).  The patients were all antiretroviral therapy-naïve, were 
asymptomatic, and had CD4+ T-cell counts above 200 per microliter at the time of 
sample acquisition.  All subjects signed informed consent documents and participated 
in protocols approved by the Conseil National de Lutte Contre le SIDA Comite 
Ethique et Juridique (Senegal) and the Harvard School of Public Health Human 
Subjects Committee. 
2.3.6	   RNA	  isolation	  and	  analysis	  
The total cellular RNA from transfected COS-7 or infected C8166 cells and the 
extracellular viral RNA fractions were purified using Stratagene’s Absolutely RNA 
mini-prep and micro-prep kits, respectively.  To pellet the viral particles, a fraction of 
the media was centrifuged for 2 hours at 4˚C at 21,000 g.  Purified RNAs from cells 
and viruses were used for RT-PCR (OneStep RT-PCR kit, Qiagen), or Rnase 
protection assay (RPA III assay, Ambion), as described by the manufacturers.  
Briefly, the Rnase protection assay was done using an antisense RNA probe 
complementary to the 1988-2137 region of HIV-2 ROD isolate containing the FLAG 
tag insertion at the end of the gag gene.  The antisense region was cloned into the 
pGEM7Zf(+) vector (Novagen) so that the T7 transcript has 41 nt of vector origin at 
its 5’ end.  This non-HIV-2 tail is used as a marker of the RNase’s digestion 
efficiency during the RPA experiment.  Up to three protected bands are expected:  
one 174-nt-long band corresponding to the FLAG-tagged gag gene and two protected 
bands corresponding to the untagged gag RNA, 49 and 101 nt long. 
For RNA derived from human PMBCs, RNA was extracted as described in 
MacNeil et al (117).  PolyA+ RNA was reverse transcribed using random hexamer 
primers.  cDNAs were amplified first using primers P1 and P2.  The P2 primer 
selectively targets and amplifies HIV-2 gag species, since its binding site is located 
downstream of the major SD site.  The P1/P2 PCR products encompassed nucleotides 
2 to 555.  A second, nested PCR was performed on an aliquot of the first P1/P2 PCR 
reaction using the P3/P4 primer pair.  The P3/P4 PCR products encompassed 
nucleotides 40-400.  The final products are predicted to be either 361-bp-long DNA, 
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for the unspliced gag species, or 219-bp-long DNA if the 142-nt-long 5’UTR intron 
was spliced out.  These PCR products were cloned into pGEM7-Zf(+) and sequenced 
to verify their identities. 
2.3.7	   Luciferase	  template	  construction	  for	  in	  vitro	  transcription	  
The full-length and truncated HIV-2 inserts (5’UTR plus the first eight codons of 
gag) were generated using PCR.  A sense primer (sNHErod) containing a NheI site 
and an antisense primer (asBsoBIrod) containing a BsoBI site were used to amplify 
the first 1-569 nucleotides of the HIV-2 genomic RNA, ROD isolate (GenBank 
M15390; genomic RNA sequence starts at 1) and the first 1-569 nucleotides minus 
the 5’UTR intron (61-202) of HIV-2 genomic RNA, respectively (55).  Sense primers 
(sNHE186, sNHE198, sNHE486) containing a NheI site in combination with an 
antisense primer (asBsoBIrod) containing a BsoBI site were used to amplify 186-569, 
198-569, and 486-569 of HIV-2 genomic RNA, ROD isolate, respectively.  The PCR 
products were digested and then inserted via NheI/BsoBI sites into the pHRL-CMV 
vector (just upstream of the second codon of the hRLuc reporter gene) (Promega).  
The C-box mutants were generated using the sNHErod primer and asBsoBIrod primer 
to amplify the first 569 nucleotides of mutant A and the mutant G constructs.  All 
constructs were checked by DNA sequencing. 
2.3.8	   In	  vitro	  transcription	  
The plasmids were linearized via BamHI digestion.  The linearized DNA templates 
were then used in mScript (Epicentre) transcription reactions to synthesize RNA.  
Following incubation, the transcription reactions were treated with Rnase-free Dnase 
followed by ammonium acetate precipitation.  The RNAs underwent 5’ capping and 
polyadenylation (mScript mRNA Production System, Epicentre) followed by 
ammonium acetate precipitation. 
2.3.9	   In	  vitro	  translation	  
Equimolar amounts (46 nM) of the various mRNAs were used in comparison 
translation reaction sets.  A 25.2-µL volume of mRNA in water was denatured at 
65˚C for 3 minutes followed by snap cooling on ice for 3 minutes.  The translation 
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mix (70 µL of rabbit reticulocyte lysate, 1 µL of amino acid mixture minus leucine, 1 
µL of amino acid mixture minus methionine, and 2.8 µL of KCl 2.5M; Flexi Rabbit 
Reticulocyte Lysate System, Promega) was added to the mRNA sample to initiate the 
reaction.  The translation reactions were incubated at 30˚C for 1 hour.  A 22.0-µL 
aliquot was taken from each sample at various time points and immediately placed on 
ice.  The aliquot tubes stayed on ice until the luciferase assays were performed. 
2.3.10	  	  Luciferase	  assays	  
Twenty microliters of each translation reaction aliquot was plated (in sets) on a 96-
well plate.  A Tropix TR717 microplate luminometer was used to autoinject each 
sample well with 100 µL of Renilla Luciferase Assay Reagent (Promega) and 
quantify/record the resulting chemiluminescence product. 
2.4	   RESULTS	  
2.4.1	   5’UTR	  splicing	  of	  gag	  mRNA	  in	  cell	  culture	  
In HIV-1, there is only one type of gag and gag-pol mRNA species, the unspliced 
genome-length RNA species.  Because HIV-2 RNA contains a predicted intron in the 
5’ UTR (52), we sought to detect the presence of a second 5’UTR-spliced gag mRNA 
species in transfected and infected cells.  RNAs derived from PBMCs from HIV-2-
seropositive but asymptomatic patients in Senegal (117) were also analyzed using 
nested PCR (RT-PCR) for the presence of 5’UTR spliced RNA. 
COS-7 (monkey kidney fibroblast) cells were transfected with full-length 
HIV-2 proviral DNA to produce viral particles.  We examined the 5’UTR of gag 
mRNA species in both the intracellular RNA fraction and the extracellular viral 
particles of the transfected cells by RT-PCR.  The intracellular RNA yielded two 
distinct products (Figure 11).  The primer asECO561 allowed us to amplify only the 
leader region of gag mRNA molecules that were not spliced at the major SD site. 
 
 30 
 
Figure 11.  Analysis of HIV-2 gag mRNA species in cell culture.   
Schematic of the two forms of HIV-2 gag (and gag-pol) mRNAs, 5’UTR-unspliced (A) and 5’UTR spliced 
(B).  (C) Gel electrophoresis analysis of RT-PCR products from COS-7 cells transfected with wild type 
HIV-2 plasmid DNA (lanes 2-5) or from C8166 cells infected with wild type HIV-2 (lanes 6-9).  The origin of 
the RNA used in the RT-PCRs, intracellular or extracellular (i.e., viral particles), is indicated below the gel.  
The primers used for the RT-PCRs are represented by arrows in (B). 
Sequencing of the gel-purified bands revealed that the larger band 
corresponded to the leader region of the unspliced genomic RNA species, while the 
smaller band corresponded to a leader region with nucleotides 61-202 missing.  The 
smaller band was clearly the 5’UTR spliced gag mRNA, since the missing sequence 
corresponds exactly to the predicted 5’UTR intron and mutation of the splice donor or 
splice acceptor site resulted in disappearance of the smaller band (data not shown).  
Furthermore, RT-PCR analysis of the viral particles produced from COS-7 cells 
revealed that the unspliced genomic RNA was encapsidated, while the 5’UTR spliced 
variant was excluded (Figure 11C). 
Viral particles produced from the transfected COS-7 cells were used to infect 
permissive C8166 (human T lymphocyte) cells.  As with the COS-7 cells, both 
spliced and unspliced gag mRNA species were found inside the infected C8166 cells, 
while only the unspliced genomic RNA was seen in C8166-produced viral particles 
(Figure 11C), suggesting that the 5’UTR spliced gag mRNA species lacks a 
functional packaging signal. 
2.4.2	   5’UTR	  splicing	  of	  gag	  mRNA	  in	  PBMCs	  from	  HIV-­‐2-­‐infected	  persons	  
Lysates from PBMCs from five HIV-2 asymptomatic seropositive patients were 
subjected to nested RT-PCR wherein the first PCR primer set was designed to 
 31 
amplify gag mRNAs, and the second primer set to further amplify a fragment within 
the 5’UTR containing a predicted intron (Figure 12). 
 
 
Figure 12.  Gel electrophoresis analysis of RT-PCR products from HIV-2-seropositive patients.   
After reverse transcription, a first PCR was performed with primers P1 and P2.  An aliquot of the P1/P2 
PCR product was then used as template for a second nested PCR with primers P3 and P4 (lanes 2-6).  
Sample identification numbers from the original reference are indicated (118).  Primers and expected 
products are described in the right panel. 
Three of the five samples produced bands corresponding to HIV-2 leader RNA.  HIV-
2 RNA was not seen in all samples, perhaps due either to sequence variation in these 
isolates that preventer primer hybridization, or the level of the viral mRNA was 
below our detection limit.  Of the three samples that yielded PCR product, two 
samples produced obvious bands, indicating 5’ UTR-spliced RNA was present; a 
third sample had lower or no obvious 5’UTR spliced RNA (Figure 12). The PCR 
products were sequenced and it was determined that the gag mRNAs were derived 
from sources other than the stock HIV-2 ROD isolates used in our laboratory (data 
not shown).  The presence of the 5’UTR spliced gag mRNA in samples derived from 
human patients confirms that this splicing event is not limited to experimental 
infections or transfections. 
2.4.3	   Effect	  of	  the	  5’UTR	  intron	  on	  Gag	  production	  in	  cell	  culture	  
Since two gag mRNA species are found in the cytoplasm of both transfected and 
infected cells, we wanted to assess their relative contributions to the overall Gag 
protein production.  To this end, we cotransfected COS-7 cells with two HIV-2 DNA 
plasmids.  One plasmid provided only the unspliced gag mRNA species because of a 
mutation in the 5’UTR SD site that prevents splicing [called SD(-)] (Figure 13A).  
The other plasmid provided the gag mRNA species lacking the 5’UTR intron through 
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deletion of nucleotides 61-202 in the proviral DNA (called Δ intron) (Figure 13B).  
To differentiate which Gag proteins came from which gag mRNA species, we 
inserted a FLAG tag at the end of the gag gene of one or the other of the 
cotransfected plasmids (Figure 13).   
RNA and proteins were harvested from the cotransfected cells, with half of 
the intracellular fraction processed for protein analysis and the other half for RNA 
analysis.  Because of the eight amino acid addition in the FLAG-tagged proteins, an 
electrophoretic migration difference could be discerned between FLAG-tagged and 
untagged Gag proteins (Figure 13C, top panel).  Those with a FLAG tag migrated 
slightly slower, and all proteins were recognized by an antibody directed against the 
capsid domain (anti-capsid antibody).  As a control, we probed the western blot with 
an anti-FLAG antibody to directly verify the presence and position of the FLAG-
tagged proteins (Figure 13C, bottom panel).  The 5’UTR Δ-intron mRNA produced 
more Gag protein than did the 5’UTR SD (-) RNA (Figure 13C, lanes 4 and 5 in top 
panel).  We also confirmed that Gag expression was not significantly affected by the 
presence or absence of the FLAG tag (Figure 13C, lanes 4 and 5 in top panel). 
 
Figure 13.  Effects of the 5’UTR intron on HIV-2 Gag protein species.   
(A) The unique gag mRNA species produced upon transfection of HIV-2 5’UTR SD(-) plasmid DNA in 
COS-7 cells.  The HIV-2 5’UTR SD(-) DNA contains mutations designed to abrogate the underlined 5’UTR 
SD site.  The substitutions are in lower case letters. (B) The unique gag mRNA species produced upon 
transfection of HIV-2 5’UTR Δ-intron plasmid DNA in COS-7 cells.  The HIV-2 5’UTR Δ-intron DNA 
contains a deletion of nucleotides 61-202, which corresponds to the 5’UTR intron.  Two versions of 5’UTR 
SD(-) and Δ-intron plasmid DNA were used, one without a tag and one with a FLAG tag inserted 
downstream of the XhoI site in the gag gene.  (C) Western blot analysis of intracellular proteins from COS-
7 cells cotransfected with equimolar amounts of 5’UTR SD(-) FLAG-tagged or untagged DNA and 5’UTR 
Δ-intron FLAG-tagged or untagged DNA.  Blots were probed with either anti-capsid primary antibody 
(top) or and anti-FLAG primary antibody (bottom).  Lane 1 contains the mock-transfected sample.  DNA 
templates used for each cotransfection are designated below each respective lane (lanes 2-5). 
 33 
Moreover, RNase protection assay (RPA) revealed that Gag expression levels varied 
according to whether or not the 5’UTR was spliced, and not simply with mRNA 
concentrations (Figure 14A).  The protein yields (corrected for mRNA 
concentrations) were quantified and are reported in Figure 14B.  To determine 
whether the Gag (FLAG-tagged or untagged) translated from mRNAs containing or 
missing the 5’UTR intron was incorporated into virions, aliquots of the cell culture 
media were centrifuged (21,000 g for 2 hours) and the viral pellets were subjected to 
protein analysis as with the intracellular fractions.  Gag derived from all mRNA 
sources was found in the virion fraction, and, as above, the mRNA species lacking the 
5’UTR intron was consistently the predominant source of the protein (Figure 14C).  
These results strongly support our hypothesis that the 5’UTRs of the two gag mRNA 
species lead to different translational efficiencies of the downstream open reading 
frame. 
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Figure 14.  Effects of the 5’UTR intron on HIV-2 gag mRNA and protein species in cell culture.   
(A) (Top) Schematic of the radioactive probe and predicted protected fragments based on the presence or 
absence of the FLAG tag. (Bottom) Rnase protection assay of intracellular RNAs.  Lane 1 contains the 
mock-transfected sample.  DNA templates used for each cotransfection are designated below each 
respective lane (lanes 2-5).  Lanes 6 and 7 represent yeast RNA used as a nonspecific target RNA control, 
incubated with and without Rnases, respectively.  (B) Quantitation of Gag protein species produced in the 
cytoplasm of cells cotransfected with 5’UTR SD(-) and Δ-intron HIV-2 plasmid DNA, with the FLAG-tag 
inserted in one or the other plasmid.  The levels of the Gag protein species produced, either FLAG-tagged 
or untagged, were quantified from a Western blot assay (Figure 13C, lanes 4 and 5) and then corrected for 
the level of their corresponding mRNA (A, lanes 4 and 5).  Three experiments were used to determine the 
fraction of Gag protein species in each cotransfection.  A schematic of the cotransfected plasmid DNAs used 
is shown below the graph.  (C) Western blots of intracellular and extracellular (virion fraction centrifuged 
from cell culture media) Gag protein.  A schematic of the cotransfected plasmid DNAs used is shown below 
the blots.  The blots show both the intracellular and extracellular fractions contain a majority of Gag 
derived from the Δ-intron construct, and that both the FLAG-tagged and untagged Gag are present 
without discrimination in the virus fraction. 
2.4.4	   In	  vitro	  translation	  of	  luciferase	  mRNA	  harboring	  5’UTR	  spliced	  or	  unspliced	  
HIV-­‐2	  leaders	  
We tested the translation of HIV-2 leaders fused to a Renilla luciferase reporter gene 
in reticulocyte lysates.  This enabled us to specifically examine the effect of the 
5’UTR on translation independently of other viral functions.  Briefly, two luciferase 
constructs were built containing either the first 569 nucleotides of the HIV-2 genomic 
RNA sequence (unspliced) or the first 569 nucleotides minus 61-202 nt (spliced) 
fused to the second codon of the Renilla luciferase reporter gene (Figure 15A).  
Following transcription, 5’ capping, and polyadenylation, the luciferase RNA 
constructs were introduced in equimolar amounts into individual rabbit reticulocyte 
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lysate translation reactions.  Aliquots were taken at set time points and luciferase 
activity at each time point was quantified using a microplate luminometer.  The 
spliced HIV-2 5’UTR luciferase construct translated approximately five times more 
efficiently than the unspliced HIV-2 5’UTR luciferase construct, illustrating that the 
removal of the 5’UTR intron significantly increased the efficiency of HIV-2 
translation (Figure 15B).  All mRNAs demonstrated similar stability in the translation 
reactions as assayed by RPA (Figure 15C). 
 
 
Figure 15.  Effects of the 5’UTR intron on translation of HIV-2 luciferase chimeras in vitro.   
(A) Wild type unspliced (top) or 5’UTR Δ-intron (bottom) HIV-2 sequences were fused to a Renilla 
luciferase open reading frame.  The absent 5’UTR intron is represented by dotted lines.  The black bar 
above the luciferase open reading frame represents the binding site of the antisense RPA probe used in (C).  
(B). Luciferase assays of translation reactions using the wild type unspliced luciferase construct (open 
squares) or the 5’UTR Δ-intron luciferase construct (closed circles).  The y-axis represents the Renilla 
luciferase activity resulting from translation of the full-length or 5’UTR spliced constructs.  The x-axis 
represents sample incubation times of the complete translation reactions.  Aliquots of the same reactions 
used to quantify luciferase activity in (B) were extracted to isolate RNA, which was then subjected to RPA.  
Decay profiles unspliced (lanes 1-5) or spliced (lanes 6-10) were similar for these RNAs.  Lanes 11 and 12 
represent yeast RNA used as a nonspecific target RNA control, incubated with and without Rnases, 
respectively. 
2.4.5	   In	  vitro	  translation	  of	  luciferase	  mRNAs	  harboring	  serially	  truncated	  HIV-­‐2	  
leaders	  
Several structural elements are affected by the 5’UTR intron splicing including the 
TAR and poly(A) signal domains and the C-box (Figure 10; compare A to B).  To 
probe the influence of these structural elements on translation, we constructed 
chimeric luciferase reporter genes fused with the HIV-2 5’UTR containing serial 
truncations of the 5’ HIV-2 leader.  The constructs produced mRNAs by T7 RNA 
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polymerase transcription beginning at nucleotide 1, 186, 198, or 486 (HIV-2 ROD 
numbering).  The 186 truncation lacked the entire TAR sequence as well as the 
poly(A) signal domain.  The 198 truncation was similar to 186 truncation with just 12 
additional nucleotides corresponding to the C-box deleted (55).  The 486 truncation 
lacked TAR, the poly(A) signal domain, the C-box, and the PBS (primer binding site) 
domain.  Translation efficiencies of these constructs were analyzed as described 
above. 
The truncation constructs exhibited progressively higher translational 
efficiencies than the full-length 5’ leader construct, but notably the 198 construct, 
which lacked the C-box, showed a disproportionately higher translational efficiency 
than the incrementally longer 186 construct, suggesting that the C-box sequence 
exerts a specific effect on translation (data not shown).  To test this, we made 
mutations in the C-box, described below. 
2.4.6	   In	  vitro	  translation	  of	  luciferase	  mRNAs	  harboring	  a	  mutated	  HIV	  5’UTR	  
leader	  
We next sought to determine whether the observed increased translational efficiency 
caused by removal of the C-box could be recapitulated by substitution of nucleotides 
within this element.  Two Renilla luciferase constructs were built containing 
substitutions that would test the effect of mutating the C-box sequence in the context 
of a full-length leader background (Figure 16A).  The cytidine nucleotides in the 189 
to 196 sequence of mutants A and G were substituted with adenine and guanine, 
respectively.  Both C-box mutants exhibited higher translational efficiencies than the 
wild type 5’ HIV-2 leader driven luciferase construct, suggesting the C-box sequence 
itself exerts translational regulation (Figure 16B). 
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Figure 16.  Effects of C-box mutations on in vitro HIV-2 luciferse translation.   
(A) RNA constructs containing C-box mutations used in the in vitro translation assays.  The substitutions 
are in lowercase letters.  (B) Luciferase activity of in vitro translation reactions using the wild type 
luciferase construct (open squares) or C-box mutated constructs including mutant G (filled circles) or 
mutant A (filled triangles).  
2.4.7	   HIV-­‐2	  C-­‐box	  mutants	  in	  cell	  culture	  
After identifying a role of the C-box region in translational regulation in vitro, we 
investigated whether mutations in the C-box could affect HIV-2 replication in cell 
culture.  To obtain viral particles, COS-7 cells were transfected with full-length HIV-
2 plasmid DNA containing the A and G substitutions in the C-box (Figure 17A). 
We first examined 5’UTR splicing of gag mRNA species in both the 
intracellular fraction and the extracellular viral particles of transfected COS-7 cells.  
RT-PCR of the total intracellular RNA yielded only one distinct band for each 
mutant, instead of the two bands observed with wild type HIV-2 transfections (Figure 
17B).  Sequencing of the gel-purified bands confirmed the lack of 5’UTR splicing for 
each mutant (data not shown).  In addition, RT-PCR analysis of the extracellular 
RNA confirmed the presence of the unspliced genomic RNA in viral particles (Figure 
17C).  These results demonstrated that there is only one species of intracellular gag 
mRNA for both C-box mutants. 
Viral particles produced from the transfected COS-7 cells were used to infect 
permissive C8166 cells.  Viral replication of both C-box mutated viruses was 
attenuated compared to wild type (Figure 17D), demonstrating that in addition to 
affecting translation, the C-box also plays an important role in viral replication. 
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Figure 17.  Effects of C-box mutations on HIV-2 replication.   
(A) Gag mRNA produced following COS-7 transfection of HIV-2 DNA mutant A or G.  The substitutions 
are in lowercase letters with the splice acceptor site underlined.  Predicted C-G box wild type base pairing 
is shown, with mismatches introduced in the A and G mutants shown for comparison.  (B) Gel 
electrophoresis analysis of intracellular RT-PCR products from COS-7 cells transfected with either mutant 
A (lanes 2-3) or mutant G (lanes 4-5) DNA plasmids.  Lane 1 contains a 100-bp DNA ladder.  (C) Gel 
electrophoresis analysis of viral particles, RT-PCR products from COS-7 cells transfected with either 
mutant A (lanes 1-2), mutant G (lanes 3-4), or wild type (lanes 5-6) DNA plasmids.  Lane 7 contains a 100-
bp DNA ladder.  (D) Replication of either wild type (open squares), mutant A (filled circles), or mutant G 
(open circles) viruses in permissive C8166 cells.  Viral production was measured by ELISA quantitation of 
viral p27 capsid protein. 
2.5	   Discussion	  
The impetus for studying the use of different gag mRNA species and their roles in 
HIV-2 replication came from several observations.  First, the long and highly 
structured leader RNA in HIV-2 would not be expected to be efficiently translated by 
a cap-dependent scanning mechanism.  Second, Lever and coworkers have proposed 
that the specificity of HIV-2 genomic RNA packaging depends on regulated gag 
translation in which viral RNA selection is mediated by a cotranslational interaction 
of the genomic RNA with its nascent Gag protein product (119).  Third, the absence 
of a 5’UTR intron was shown to favor translation of model SIV RNAs, although the 
5’UTR constructs used in this prior study were truncated ~150 nt upstream of the gag 
AUG start codon (109).  Here we show that two gag mRNA species exist in HIV-2 in 
culture and in patients, differing only by an intron in the 5’UTR.  The species missing 
this intron is a better template for gag translation. 
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Figure 18.  Model of the roles of the two forms of gag (or gag-pol) RNA species during HIV-2 replication.   
Both 5’UTR-spliced and –unspliced gag HIV-2 RNA molecules are exported from the nucleus into the 
cytoplasm where they serve as mRNA for Gag and Gag-Pol protein expression (small arrowheads).  One 
functional difference between the two RNA species is that the 5’UTR spliced molecule is a better substrate 
for gag translation (this work).  However, only the 5’UTR unspliced molecule is a substrate for packaging 
into assembling viral particles (this work).  Furthermore, prior translation of the unspliced gag HIV-2 RNA 
appears to be necessary for its selection for packaging (in dimeric form) (119).  A cotranslational binding 
event (double arrowhead) between the unspliced gag mRNA and the nascent Gag protein helps to select this 
RNA for packaging (119). 
Introns entirely contained within the 5’UTR occur in about 25% of metazoan 
mRNAs and average between 100 and 200 nt in length (120,121).  For example, 
removal of a 5’UTR intron has been shown to have a significant translational 
stimulatory effect for various cellular and viral mRNAs including platelet-derived 
growth factor B chain/c-sis and β1,4 galactosyltransferase (69,122,123).  5’UTR 
splicing can affect translation in several ways.  Removal of secondary structures 
within the 5’UTR may increase translation efficiency at several stages of the 
translation initiation process, including scanning by the initiating ribosome and AUG 
recognition (65).  In HIV-2, splicing of the 5’UTR intron removes half of the TAR 
sequence, the entire poly(A) signal, and the C-box region, thus decreasing the size of 
the 5’UTR spliced leader RNA to a size similar to that of the HIV-1 leader (from 545 
to 405 nt, as compared to 335 nt for HIV-1) (Figure 10B).  No internal 5’UTR 
splicing has been shown to exist in HIV-1, where the most proximal splicing event is 
initiated using the major SD site (107).  We observed in the course of this study that 
translational efficiency of a reporter construct fused to an HIV-1 full-length leader 
was comparable to the 5’UTR Δ-intron HIV-2 leader construct (data not shown); 
thus, the translationally inefficient HIV-2 leader can be converted to one with higher 
efficiency (i.e., comparable to HIV-1) through 5’UTR splicing.  Splicing may also 
contribute to translational efficiency through increased accessibility of the 5’ methyl-
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G cap in HIV-2 mRNA, since the 3’ half of the TAR structure (nucleotides 61-123), 
which normally base pairs to the 5’ end of the mRNA, is intronic.  A more accessible 
5’ cap structure would increase translation initiation efficiency (124), and in vitro 
studies using HIV-1 5’UTR have shown that TAR has a significant inhibitory effect 
on translation (48,100,125,126).   
It is notable that 5’UTR splicing removes a pyrimidine-rich sequence known 
as the C-box.  The C-box was previously shown to influence HIV-2 RNA 
dimerization through base pairing with the G-box, an area encompassing the gag start 
codon (54,60).  A similar base pairing interaction has been demonstrated in HIV-1, 
where it affects the equilibrium between two proposed 5’UTR conformations.  It was 
demonstrated to influence genomic RNA dimerization both in vitro (61) and in cell 
culture (56) although evidence for 5’UTR conformational control of HIV-1 
translation was not observed using a transfected reporter construct (53).  In the 
present study, we showed that viral replication of C-box substitution mutants is 
impaired.  Our attempts to make compensatory mutations in the G-box were 
confounded by the overlap of the G-box with a consensus Kozak sequence 
surrounding the gag AUG start codon as well as the obligatory myristoylation signal 
at the subsequent codons of gag (data not shown).  Interestingly, the same C-box 
mutations increased translational efficiency of 5’UTR unspliced RNA construct in 
vitro, suggesting a role for the C-box in translational regulation of the downstream 
gene.  In addition to their effects on translation, the C-box substitution mutants do not 
undergo 5’UTR splicing in transfected cells.  Examination of the C-box region and 
surrounding sequence revealed that it encompasses the conserved polypyrimidine 
tract of the splice acceptor site whose disruption likely explains the absence of 5’UTR 
splicing in these mutants (Figure 17A)(127-129).   
Surprisingly, despite the conservation of the 5’UTR splice sites among HIV-1 
and SIV strains, abrogation of 5’UTR splicing by mutagenesis of the UTR splice 
acceptor or donor sites did not strongly affect replication of HIV-2 in immortal 
C8166 cells (data not shown).   This suggests either that translational efficiency is not 
the replication rate-limiting factor in viruses grown in this cell line (which is used 
because it is one of the few cell lines that support robust HIV-2 replication), or that 
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5’UTR splicing becomes important only during a bona fide infection in a host.  This 
prompted us to examine whether 5’UTR splicing was evident in clinical isolates.  The 
observation of 5’UTR splicing in the PBMCs of HIV-2-infected individuals (Figure 
12) attests to its physiological relevance, and the role(s) and regulation of 5’UTR 
splicing will continue to be explored.  It is also possible that several mechanisms of 
translational activation are available to HIV-2/SIV, including the use of internal 
ribosome entry sites as recently reported (96,98).  In the case where UTR splicing 
was inhibited by splice-site mutations, it is possible that increased internal ribosome 
entry site activity could compensate.  The interplay between these two proposed 
mechanisms may well represent another level of regulation of translation and 
replication. 
Unspliced genome-length HIV RNA can serve either as mRNA or a 
packageable genomic RNA, or both (Figure 18)(130).  The present study suggests a 
specialized translation-only role for HIV-2 gag RNA following 5’UTR splicing since 
it augments translation, is not encapsidated to detectable levels (Figure 11), and 
coexpression of homologous 5’UTR spliced and unspliced gag mRNAs showed a 
strong translational bias toward the spliced species (Figure 13C).  Previous research 
has shown that recognition of the packaging signal (Ψ) by Gag is necessary for 
initiation of HIV genomic RNA encapsidation and suggests that the transition 
between translation and packaging of the HIV genomic RNA relies on a switch-like 
mechanism that affects packaging signal presentation (112).  Removal of secondary 
structure in the 5’UTR by splicing could result in an improperly presented packaging 
signal.  In fact, the C-box, through its interaction with the G-box, has been shown to 
influence the presentation of the encapsidation and dimerization signals in vitro 
(58,60).  Taken together, our results suggest a role for the 5’UTR splicing and the C-
box in the concomitant regulation of gag translation and packaging during the HIV-2 
replication cycle. 
2.6	   Acknowledgements	  
We thank Tayyba Baig, Leila Sears, and Mary Ellenbecker for critical reading of the 
manuscript.  This work was funded by the National Institute of Allergy and Infectious 
 42 
Diseases grant AI45388 to J.S.L., AI6274-04 to P.J.K, and a Grant-In-Aid of 
Research from Sigma Xi, the Scientific Research Society, to C.L.S.  The plasmid 
pROD10 was provided by the EU Programme EVA/MRC Centralised Facility for 
AIDS Reagents, NIBSC, UK (Grants QLK2-CT-1999-00609 and GP828102).  The 
following reagents were obtained through the AIDS Research and Reference Reagent 
Program, Division of AIDS, NIAID, NIH: C8166-145 (Cat# 404) from Dr. Robert 
Gallo and saquinavir (Cat# 4658). 
 43 
CHAPTER	  THREE:	  	  VIRAL	  SELEX	  REVEALS	  INDIVIDUAL	  AND	  COOPERATIVE	  
ROLES	  OF	  THE	  C-­‐	  AND	  G-­‐BOXES	  IN	  HIV-­‐2	  REPLICATION	  
 
Christy L. Strong, Jean-Marc Lanchy and J. Stephen Lodmell 
 
 
Division of Biological Sciences, University of Montana, Missoula, MT  59812, USA 
 
Corresponding author:  J. Stephen Lodmell 
 
 
This chapter is a modified version of the manuscript submitted to the RNA Journal. 
 
This manuscript represents the experiments done by the author of this dissertation 
with the exception of the forced evolution, 2 nt and 5 nt mutation cell culture studies 
of HIV-2, which were performed by Dr. Jean-Marc Lanchy (Figures 20 and 21, Table 
6). 
 44 
 
3.1	   Abstract	  
  The 5’UTR of HIV-2 genomic RNA contains signaling motifs that regulate specific 
steps of the replication cycle.  Two motifs of interest are the C- and G-boxes.  The C-
box is found in the 5’ untranslated region upstream of the primer binding site, while 
the G-box is found downstream of the major splice donor site, encompassing the gag 
start codon and flanking nucleotides.  Together the C- and G-boxes form a long-range 
base pairing interaction called the CGI.  We and others have previously shown that 
formation of the CGI affects RNA dimerization in vitro and the positions of the C- 
and G-boxes are suggestive of potential roles of the CGI in other steps of HIV-2 
replication.  Therefore, we attempted to elucidate the role of the CGI using a viral 
SELEX approach.  We constructed proviral DNA libraries containing randomized 
regions of the C-box or G-box paired with wild type or mutant base pairing partners.  
These proviral DNA libraries were transfected into COS-7 cells to produce viral 
libraries that were then used to infect permissive C8166 cells.  The “winner” viruses 
were sequenced and further characterized.  Our results demonstrate that there is 
strong selective pressure favoring viruses that can form a branched CGI.  In addition, 
we show that the mutation of the C-box alone can enhance RNA encapsidation and 
mutation of the G-box can alter the levels of Gag protein isoforms.  These results 
suggest coordinated regulation of RNA translation, dimerization, and encapsidation 
during HIV-2 replication.  
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3.2	   Introduction	  
HIV replication is highly orchestrated, requiring tight regulation of each step of the 
viral cycle to ensure successful virus synthesis and propagation.  The 5’ untranslated 
region (5’UTR) of the HIV RNA genome contains several regulatory motifs 
including TAR (transactivation responsive element), the polyadenylation signal, the 
C-box, the primer binding site (PBS), stem loop 1 (SL1), and the G-box (Figure 19) 
(46,47).  The C-box, a pyrimidine-rich region, has been implicated in the regulation 
of genomic RNA dimerization and translation through a base pairing interaction with 
the G-box, a purine-rich region encompassing the gag start codon and flanking 
nucleotides (Figure 19) (47,131). 
 
 
Figure 19. Schematic of HIV-2 genomic RNA.   
TAR, poly(A) signal, C-box, PBS, SL1, major SD, G-box, and gag represent the trans-activation region, the 
poly(A) signal domain, the core of the C-box, the tRNA primer binding site, the stem loop one dimerization 
signal, the major splice donor site, the core of the G-box, and the Gag protein coding region, respectively.  A 
proposed C-box-G-box interaction (CGI) is illustrated below.  The AUG initiation codon of Gag, found in 
the G-box, is underlined. 
Several previous studies suggested that both the presence of the C- and G-
boxes and their ability to base pair affected dimerization in HIV-2 (47,55,58,60,132) 
and in HIV-1 (53,56,61,62).  It was postulated that the C-box-G-box interaction 
termed CGI in HIV-2 (54) or U5-AUG duplex in HIV-1 (61) could modulate 
translation through occlusion of the gag start codon encompassed by the G-box 
(47,60-62).  Mutational studies designed to test two proposed structural 
conformations of the HIV-1 leader, namely the branched multiple-hairpin (BMH) and 
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the long distance interaction (LDI) conformations, did not appear to support a role for 
the U5-AUG duplex, which would be disrupted in a large-scale LDI-BMH 
conversion, in translational control (53).  However, the main focus of that study was 
the BMH-LDI interconversion and did not directly probe the U5-AUG duplex.  In 
HIV-2, directed mutagenesis of the leader suggested that the C-box does play a role 
in translational regulation, as deletion or mutation of the C-box to disrupt the CGI led 
to enhanced translation of HIV-2 chimeric reporter constructs (131). 
HIV-2 and SIVmac are unique among the primate lentiviruses in that they have 
a conserved intron contained entirely within the 5’ untranslated leader region 
(52,109,111,131).  The C-box is located at the 3’end of the intron and is completely 
removed upon 5’UTR splicing.  Previously, we have shown that removal of this 
intron results in increased translation of gag mRNA, apparently through the combined 
effects of overall shortening of the leader and removal of secondary structure that 
could impede ribosomal scanning (131).  Detailed in vitro translation studies 
demonstrated that mutations or deletions of the C-box that were designed to disrupt 
the proposed CGI resulted in increased translational efficiency.  However, attempts to 
directly test the CGI by making compensatory mutations in the G-box were 
confounded by the exquisite sensitivity of the G-box to changes, apparently because 
the G-box encompasses the Kozak context for the gag start codon (131).  Thus the 
importance and the role(s) of the CGI have been difficult to address experimentally. 
Here we used a viral SELEX technique (132,133) to generate viable virus 
variants at the C-box or the G-box.  When either of these sequences was randomized 
alone, wild type-like sequences rapidly emerged as the dominant species.  This led us 
to question whether this was the result of local sequence constraints or the 
requirement to maintain base pairing compatibility with another viral sequence.  To 
address this, we built two additional proviral DNA libraries, one that was 
simultaneously randomized at both the C- and the G-box, and one that contained a 
lethal mutated G-box sequence combined with a randomized C-box.  Each of these 
libraries was designed to test, with the use of non-native sequence in the C- and/or G-
box, whether base pairing between these sites was important for virus viability.  
These co-randomization and forced evolution experiments reproducibly demonstrated 
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that the requirement for base pairing in the CGI is finely tuned, with lack of base 
pairing being as deleterious as overly stable extended base pairing arrangements 
between these elements.  Sequence analysis of winning viruses suggested that the 
CGI is directly involved in a branched three-way RNA junction, consistent with a 
previously proposed model (47). 
3.3	   Material	  and	  Methods	  
3.3.1	   Construction	  of	  plasmids	  for	  generation	  of	  randomized	  C-­‐box,	  G-­‐box,	  co-­‐
randomized,	  and	  forced	  evolution	  libraries	  
To prevent contamination by wild type proviral DNA plasmid in the C-box, G-box, 
co-randomized, and forced evolution libraries, we used parent plasmids called 
pSCR2, pAUG1, pCboxg, and pGboxc, respectively.  The pSCR2, pAUG1, pCboxg, 
and pGboxc plasmids harbor deleterious mutations in the encapsidation signal (132), 
the gag initiation codon, the C-box region (194-GGUGG-199), and the G-box region 
(540-CCACC-545), respectively. 
To create a vector for generating the C-box, co-randomized, and forced 
evolution libraries, a derivative of pSCR2 plasmid called pSCR2AfeIΔ(173-2030) 
was constructed, in which a fragment encompassing nt 173 to 2030 of the viral 
genome, including part of the noncoding region, and most of the Gag coding region 
up to the XhoI site was deleted and substituted with eight nucleotides to introduce a 
unique AfeI restriction site and a spacer region.  All nucleotide numbering in the 
present study is referenced to the RNA sequence of HIV-2 (ROD isolate, GenBank 
no. M15390).  The cloning region in the pSCR2AfeIΔ(173-2030) vector is as follows:  
5’-160GCCAGTTAGAAGCgctaagtc180/ /2031CTCGAG-3’, where AfeI and XhoI sites 
are underlined and the lowercase letters indicate the changed nucleotides. 
pSCR2AfeIΔ(173-2030) was constructed as follows.  A fragment containing the long 
terminal repeat (LTR) sequence up to nt 172, followed by a 14-nt sequence 
containing the remaining half of the AfeI site, the spacer region, and the XhoI site, 
was amplified using as sense primer (M13 forward (-41) binding upstream of a 
unique AatII site) and an antisense primer (asXhoCbox, containing the XhoI site, 
spacer region, and AfeI site).  The amplified product was digested with AatII and 
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XhoI, and ligated into pSCR2 plasmid vector missing the original AatII-XhoI 
fragment.  The ligated product was transformed in Escherichia coli DH5α cells, and 
ampicillan-resistant colonies were selected, followed by plasmid purification and 
sequencing. 
To create a vector generating the G-box randomized library, a derivative of 
pAUG1 plasmid called pAUG1AfeΔ was constructed, in which a fragment 
encompassing nt 498 to 2030 was deleted and substituted with eight nucleotides to 
introduce a unique AfeI restriction site and a spacer region.  The cloning region of the 
pAUG1AfeΔ(498-2030) vector is as follows:  5’-
481ACACCAAAAACTGTAGCgctaagtc505//2031CTCGAG-3’, where AfeI and XhoI 
sites are underlined and the lowercase letters indicate the changed nucleotides.  
pAUG1AfeΔ(498-2030) was constructed as follows.  A fragment containing the LTR 
sequence up to nt 498, followed by a 14-nt sequence containing the remaining half of 
the AfeI site, the spacer region, and the XhoI site, was amplified using a sense primer 
(M13 forward (-41) binding upstream of a unique AatII site) and an antisense primer 
(asXhoGbox, containing the XhoI site, spacer region, and AfeI site).  The amplified 
product was digested with AatII and XhoI, and ligated into the pAUG1 plasmid vector 
missing the original AatII-XhoI fragment.  The ligated product was transformed in 
Escherichia coli DH5α cells, and ampicillin-resistant colonies were selected, 
followed by plasmid purification and sequencing. 
3.3.2	   Generation	  of	  the	  C-­‐box,	  G-­‐box,	  co-­‐randomized,	  and	  forced	  evolution	  
proviral	  DNA	  libraries	  
To generate the proviral DNA libraries, we used a single-step ligation dependent 
DNA cloning protocol (In-fusion; Clontech) as described previously (132).  Both the 
pSCR2AfeΔ and pAUG1AfeΔ vectors were prepared by an AfeI and XhoI digestion, 
followed by gel electrophoresis and gel extraction (5PRIME). 
 To construct the C-box randomized insert, a PCR product (nt 157 to 2050) 
was generated using a mutagenic primer (sCboxrandom) with degenerate nucleotides 
at positions 194 to 199, an antisense primer (asROD2050), and the pCboxg plasmid 
as a template.  To construct the G-box randomized insert, a PCR product (nt 483 to 
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2050) was generated using a mutagenic primer (sGboxrandom) with degenerate 
nucleotides at positions 540 to 545, an antisense primer (asROD2050), and the 
pSCR2 plasmid as a template.  To contruct the co-randomized insert, overlap 
extension two PCR products was performed, followed by a PCR using a sense primer 
(sROD157) and an antisense primer (asROD2050).  The first PCR product (157-571) 
was generated using a mutagenic sense primer (sCboxrandom) with degenerate 
nucleotides at positions 194 to 199, a mutagenic antisense primer (asGboxrandom) 
with degenerate nucleotides at positions 540 to 545, and the pCboxg plasmid as a 
template.  The second PCR product (551-2050) was generated using a sense primer 
(sROD551), an antisense primer (asROD2050), and the pCboxg plasmid as a 
template.  To construct the forced evolution randomized insert, a PCR product (nt 
157-2050) was generated using a mutagenic sense primer (sCboxrandom) with 
degenerate nucleotides at positions 194 to 199, an antisense primer (asROD2050), 
and the pGboxc plasmid as a template.  All PCR products (randomized inserts) were 
purified by gel electrophoresis. 
The C-box randomized, co-randomized, or forced evolution randomized insert 
was combined with the digested pSCR2AfeIΔ(173-2030) vector at a 2:1 ratio in an 
infusion reaction.  The G-box randomized insert was cloned into the digested 
pAUG1AfeIΔ(498-2030) vector at a 2:1 ratio using the Infusion Clontech kit.  Each 
of the resulting recombined products were transformed into E. coli DH5α cells and 
DNA was extracted from bulk transformation reactions to obtain each of the 
randomized proviral DNA libraries.  Degeneracy of the proviral DNA libraries was 
checked by sequencing. 
3.3.3	   Construction	  of	  individual	  plasmids	  with	  C-­‐box	  and	  G-­‐box	  mutations	  
To construct full-length plasmids with mutated and non-mutated C-box and G-box 
regions, we used the In-Fusion strategy described previously with the 
pSCR2AfeIΔ(173-2030) vector but with inserts that contained the desired C-box and 
G-box sequences.  Each insert was produced using overlap extension with two PCR 
products as previously described.  All overlap extensions contained a PCR product 
(551-2050) generated using a sense primer (sROD551), an antisense primer 
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(asROD2050), and the pCboxg plasmid as a template.  The Cbox119 pcr product was 
generated with a sense primer (sCboxCLS119), an antisense primer (asGboxwt), and 
the pCboxg plasmid as a template.  The Gbox119 PCR product was generated with a 
sense primer (sCboxwt), an antisense primer (asGboxCLS119), and the pGboxc 
plasmid as a template.  The CLS-119 PCR product was generated with a sense primer 
(sCboxCLS119), an antisense primer (asGboxCLS119), and the pGboxc plasmid as a 
template.  The CLS-120, CLS121, and CLS-005 proviral DNAs were constructed as 
described for CLS-119, using their designated primers. 
 
3.3.4	   Cell	  culture	  and	  transfection	  
COS-7 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal calf serum, glutamine, penicillin, and streptomycin 
(Invitrogen).  COS-7 cells were transiently transfected using the Trans-IT-COS 
transfection kit (Mirus).  Cells and media were harvested 24-48 hours post-
transfection.  The amount of HIV-2 particles in the media was determined by 
measurement of the viral capsid (Cap27) protein levels (Retro-Tek SIV p27 Antigen 
ELISA kit; Zeptometrix). 
 
3.3.5	   Cell	  culture	  and	  infection	  
C8166 cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium 
supplemented with 10% fetal calf serum, glutamine, penicillin, and streptomycin 
(Invitrogen).  C8166 cells (2 x 104 cells) were infected with media from COS-7 
transfected cells (10 ng of HIV-2 capsid as determined by ELISA).  The C8166 cells 
were washed twice 12 hours post-infection, followed by resuspension in RPMI/fetal 
bovine serum.  A media aliquot (day 0) was taken to serve as a reference.  A daily 
aliquot of media was harvested, spun to remove cells, and then the supernatant frozen 
at -80˚C.  Viral replication was followed by quantification of the Cap27 protein 
(Retro-Tek SIV p27 Antigen ELISA kit; Zeptometrix) or reverse transcriptase 
(Amersham Biosciences Quan-T-RT assay system) levels in the supernatant sample. 
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3.3.6	   Protein	  isolation	  and	  analysis	  
Intracellular COS-7 RNA and proteins were harvested 48 hours after transfection by 
washing and scraping cells in phosphate-buffered saline.  To prevent Gag cleavages, 
10 µM (final concentration) of saquinavir (an HIV protease inhibitor) was added to 
the media of the transfected COS-7 cells 24 hours before harvesting.  One half of the 
cells were harvested in RNA lysis buffer for genomic RNA quantitation (see below).  
The remaining half of the cells was lysed in radioimmunoprecipitation assay buffer 
(Santa Cruz Biotechnology Inc.; Tris-HCl, 50 mM, pH 7.4, NaCl 150 mM, SDS 
0.1%, Nonidet P-40 0.1%, 0.5% sodium deoxycholate with protease inhibitors).  
Following lysis on ice, samples were fractionated on SDS-8% polyacrylamide gels.  
Electrotransfer onto polyvinylidene difluoride (PVDF) membranes was then 
performed.  To visualize Gag proteins, the western blot was probed using the primary 
antibody biotin-labeled anti-capsid antibody (p27 ELISA kit from Zeptometrix) 
followed by incubation with streptavidin-horseradish peroxidase (p27 ELISA kit from 
Zeptometrix).  Detection was performed by electrochemiluminescence (ECL Plus 
Western Blotting Detection Reagents from GE Healthcare) using a Fujifilm LAS-
3000. 
Supernatants from transfected cells were filtrated through 0.45 µm filters and 
virions were collected by a 1-hour centrifugation at 21,000 g/4˚C.  Pelleted virions 
were resuspended in radioimmunoprecipitation assay buffer and Gag proteins were 
visualized as described above.  
3.3.7	   RNA	  isolation	  and	  analysis	  
Total cellular RNA and extracellular viral RNA fractions from transfected COS-7 
cultures were purified with the Absolutely RNA mini-prep kit (Stratagene).  Virions 
were pelleted by centrifuging an aliquot of media for 1-hour at 21,000 g/4˚C.  
Purified RNAs from the cells and viruses were used in Rnase protection assays (RPA 
III kit, Ambion).  The Rnase protection assay was performed using an antisense RNA 
probe complementary to the 401-562 region of HIV-2 ROD isolate.  The antisense 
region was cloned into the pGEM7Zf(+) vector (Novagen) allowing for 41 nts of 
vector origin at the 5’ end of the T7 transcript.  This non-HIV-2 tail was used to 
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confirm Rnase’s digestion efficiency during the RPA experiment.  Three protected 
bands are expected:  one 162 nt band corresponding to the 401-562 region (wild type 
G-box), one 139 nt band corresponding to the 401-539 region (mutant G-box), and 
one 17 nt band corresponding to the 546-562 region (mutant G-box). 
3.3.8	   Luciferase	  template	  construction	  for	  in	  vitro	  transcription	  
Luciferase chimeric constructs were built containing the first 920 nucleotides of HIV-
2 fused to a Renilla luciferase reporter gene.  The HIV-2 inserts (1-920 nt) were 
generated using PCR.  A sense primer (sNHErod) containing a NheI site and an 
antisense primer (asBsoBI920) containing a BsoBI site were used to amplify the first 
1-920 nucleotides of the C-box119, G-box119, and CLS-119 constructs as well as 
wild type HIV-2 genomic RNA, ROD isolate (GenBank no. M15390; genomic 
sequence start at 1).  All constructs were checked by DNA sequencing. 
3.3.9	   In	  vitro	  transcription	  
The HIV-2-luciferase plasmids were linearized via ClaI digestion. The linearized 
DNA templates were then used in transcription reactions to synthesize RNA (mScript 
mRNA Production System, Epicentre).  Following completion of the incubation, the 
reactions were treated with RNase-free DNase, followed by ammonium acetate 
precipitation.  The RNAs were then 5’ capped and polyadenylated (mScript mRNA 
Production System, Epicentre), followed by ammonium acetate precipitation. 
3.3.10	  	  In	  vitro	  translation	  and	  protein	  analysis	  
Comparison translation reactions were performed using equimolar amounts (46 nM) 
of the tested RNAs.  The RNAs were initially denatured in water (final volume of 
25.2 µL) at 65˚C, then snap-cooled on ice for 3 minutes.  The translation mix (70 µL 
rabbit reticulocyte lysate, 1 µL amino acid mixture minus methionine, 1 µL [35S] 
methionine (Perkin Elmer), and 2.8 µL KCl 2.5M; Flexi Rabbit Reticulocyte Lysate 
System, Promega) was added to each mRNA sample to initiate the reaction.  The 
translation reactions were then incubated at 30˚C.  Five minutes into the 45-minute 
incubation, each reaction was spiked with 1 mM non-radioactive methionine.  The 
samples were again placed at 30˚C.  Upon completion of the incubation, reactions 
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were placed on ice.  A 10 µL aliquot of each reaction was combined with 20 µL of 
4M urea protein loading dye.  The samples were denatured at 90˚C for 2 minutes and 
run on a SDS-polyacrylamide gel.  The radioactive protein isoforms were visualized 
using a Fuji FLA-3000.  
3.3.11	  	  Prediction	  of	  RNA	  secondary	  structures	  
Mfold version 3 (134) was used to predict the secondary structures for the wild type 
HIV-2 ROD and the 34 individual clonal RNA sequences isolated from the co-
randomized viral library at day 40 and 56.  The analyzed RNA fragments represent 
the first 580 nucleotides of the genomic RNA sequences.  The software used is found 
on the mfold server (http://mfold.rna.albany.edu/?q=mfold/RNA-Folding-Form) 
(134).  The ten most stable secondary structures for each RNA were visually analyzed 
and the base pairing partners of the C-box and G-box, presence or absence of the 
CGI, and the type of CGI were recorded. 
3.4	   Results	  
3.4.1	   Mutations	  in	  the	  C-­‐box	  and	  G-­‐box	  are	  deleterious	  to	  HIV-­‐2	  in	  cell	  culture	  
We first addressed the role of the CGI in HIV-2 replication by investigating the 
effects of mutations and presumed compensatory mutations of the C and G-boxes.  
Mutant viruses containing five altered nucleotides in either the C-box (positions 194-
198) or the G-box (positions 541-545) were replication-defective in cell culture 
(Figure 20).  The compensatory mutant, containing simultaneously mutated C- and G-
boxes, failed to rescue replication (Figure 20). 
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Figure 20. Five nucleotide compensatory mutation analysis of the CGI.   
(Left panel) Schematic of the 5 nt mutation series.  Only the C-box and G-box regions of the unspliced 
genomic RNAs are represented.  Nucleotide positions that are mutated are in bold lowercase letters.  (Right 
panel) Replication kinetics of the wild type, the 5 nt C-box mutant, the 5 nt G-box mutant, and the 5 nt 
double mutant viruses in C8166 cells.  Equal amounts of viral particles (10 ng of p27 capsid, as determined 
by ELISA), produced during COS-7 transfection were used to infect C8155 cells.  Viral replication was 
measured using reverse transcriptase quantification.  Numbers below the x-axis represent days post-
infection.  The y-axis error bars represent the standard error of duplicate experiments.  
Because five-nucleotides of the C- or G-box were lethal, we attempted more subtle 
two-nucleotide mutations in the C-box (positions 197-198), G-box (positions 541-
542), and compensatory mutations in both (Figure 21).  The 2 nt C-box mutant 
reached close to wild type replication levels (Figure 21).  The 2 nt G-box mutant 
showed reduced levels of replication.  Interestingly, combining the C-box and G-box 
mutations resulted in viruses that were replication defective (Figure 21).   
 
Figure 21.  Two nucleotide compensatory mutation analysis of the CGI.   
(Left panel) Schematic of the 2 nt mutation series.  Only the C-box and G-box regions of the unspliced 
genomic RNAs are represented.  Nucleotide positions that are mutated are in bold lowercase letters. (Right 
panel) Replication kinetics of wild type, the 2 nt C-box mutant, the 2 nt G-box mutant, and the 2 nt double 
mutant viruses in C8166 cells.  Equal amounts of viral particles (10 ng of p27 capsid, as determined by 
ELISA), produced during COS-7 transfection were used to infect C8166 cells.  Viral replication was 
measured using p27 quantification.  Numbers below the x-axis represent days post-infection.  The y-axis 
bars represent the standard error of duplicate experiments. 
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Thus our first attempts to create a non-wild type CGI using compensatory mutations 
resulted in replication-defective viruses, hampering analysis of sequence 
requirements using cell culture studies.  To circumvent the limitations of building and 
testing substitution mutants one at a time, we adopted a viral SELEX approach. 
3.4.2	   Viral	  SELEX	  of	  the	  C-­‐box	  and	  G-­‐box	  randomized	  libraries	  
Six nucleotides of the C-box (nucleotides 194-199) or six nucleotides of the G-box 
(nucleotides 540-545) were randomized using degenerate primers to make PCR 
libraries containing up to 4096 possible sequence combinations of either the C-box or 
the G-box region of the genome.  Each PCR library was used to construct a library of 
full-length infectious HIV-2 proviral DNA clones using a ligation-independent 
protocol (see Material and Methods).  The degeneracy of each randomized proviral 
DNA library was verified through pool sequencing.  The C-box and G-box proviral 
DNA libraries were independently transfected into COS-7 cells to generate virus.  
COS-7 cytoplasmic and media fractions for both libraries were harvested.  Viral 
RNAs purified from the media fraction were examined for degeneracy of the 
randomized region (Figure 22).   
 
 
Figure 22.  C-box and G-box randomized libraries.   
(Top panel) Schematic of the C-box and G-box elements in the two randomized libraries.  Only the C-box 
and G-box regions of the unspliced genomic RNAs are represented.  Nucleotide positions containing an “N” 
have an equal probability of being A, C, G, or U.  (Bottom panel)  Viral RNAs purified from the media 
fraction of transfected COS-7 cells were reverse transcribed into cDNA.  Primer extension of the different 
cDNA showed degeneracy of the C-box randomized region in the C-box randomized library (Bottom; left) 
and the G-box randomized region in the G-box randomized viral library (Bottom; right). 
Virus harvested from the media fraction was used to infect permissive C8166 cells.  
Emergence of dominant virus sequences was quite rapid, with the two winning 
sequences for the G-box library (5’ 540-UGGGRG, where R is G or wt A) 
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dominating by day 13 (compare Table 2 to Table 3) and the wild type C-box 
sequence (5’194-CUCUCC) dominating the C-box library by day 20 (Table 4).   
Table 2.  Sequences obtained from the G-box COS-7 viral library. 
Individual clone sequencing of the six-nt randomized G-box virus library contained within the media 
fraction of the transfected COS-7 culture.  This virus library was used to infect permissive C8166 cells. 
  Nucleotide at position: Category and clone 
number 540 541 542 543 544 545 
Extracellular 
vRNA (day 0) 
      
wild type U G G G A G 
CLS-1 U A G A G U 
CLS-2 G A C A C G 
CLS-3 G C A G A A 
CLS-4 C G G U G U 
CLS-5 A U C A U G 
CLS-6 U A C A A C 
CLS-7 A A A A G C 
CLS-8 C G G A A G 
CLS-9 A A G A A G 
CLS-10 U G G A G G 
CLS-11 G G U A G A 
CLS-12 C A G A G A 
CLS-13 C U G C A A 
CLS-14 G G G C G U 
CLS-15 G A C U G U 
 
Table 3.  Pool sequencing of the G-box region of viruses from the six-nt randomized G-box library that 
were selected for after several rounds of infection in C8166 cells. 
Nucleotide at position: Time post 
infection 540 541 542 543 544 545 
Day 5 G/U G G G A/G G 
Day 9 G/U G G G A/G G 
Day 13 U G G G A/G G 
Day 19 U G G G A/G G 
Day 27 U G G G A/G G 
 
Table 4. Pool sequencing of the C-box region of viruses from the six-nt randomized C-box virus library that 
were selected for after several rounds of infection in C8166 cells. 
Nucleotide at position: Time post 
infection 194 195 196 197 198 199 
Day 6 C/U C/U N N N N 
Day 12 C U C U N N 
Day 14 C U C U C N 
Day 20 C U C U C C 
Day 26 C U C U C C 
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The more rapid emergence of dominant sequences suggested there was stronger 
selective pressure on the G-box than the C-box.  By day 5, four out of the six 
positions in the randomized G-box were wild type, with the two remaining positions 
540 and 544 being U or G and A or G, respectively (Table 3).  The C-box, on the 
other hand, contained pyrimidines at positions 194 and 195 by day 6, with the 
remaining four positions (196-199) still relatively diverse (Table 4).  However, only 
the wild type C-box sequence was found by day 20. 
The rapid emergence of wild type sequence seen in both the C-box and G-box 
randomized libraries made us ask whether this was because of local sequence 
requirements, mutual base pairing requirements (i.e. CGI), or both.  To address this 
question we built a new library (Figure 23) with both the C-box (positions 194-199) 
and G-box (positions 540-545) randomized on the same proviral DNA. 
 
Figure 23.  Co-randomized viral library.   
Only the C-box and G-box regions of the unspliced genomic RNAs are represented.  Nucleotide positions 
containing an “N” have an equal probability of being A, C, G, or U. 
3.4.3	   Viral	  SELEX	  of	  the	  co-­‐randomized	  library	  
The co-randomized viral library (Figure 23) was constructed and tested using the 
same techniques as described for the C-box and G-box libraries.  Mfold (134) 
prediction of secondary structure of all winner viral sequences revealed several key 
characteristics.  First, non-wild type viruses represented a large proportion of selected 
viruses on day 40 (12 out of 17) and day 56 (9 out of 17) (Table 5). 
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Table 5.  C-box and G-box sequences of viruses that were selected for in the co-randomized viral library 
following several rounds of infection in C8166 cells.  The CGI found in the lowest energy structure is either 
(a) the branched CGI or (b) the extended CGI.  
Time 
post 
infection 
and clone 
number 
 
Nucleotide at position: 
 
CGI 
type 
 194 195 196 197 198 199 540 541 542 543 544 545 a b 
40 dpi               
wild 
type 
C U C U C C U G G G A G X  
CLS-88 U G A G A A C U G G G G X  
CLS-
89:93 
C U C U C C U G G G A G X  
CLS-94 C C A A C C U G G G A G X  
CLS-95 G G A U U C U G G G A G X  
CLS-96 C C A A C C U G G U A A X  
CLS-97 U G C C G G G U U G C A X  
CLS-98 U G C C G G U G G G A G  X 
CLS-99 C C A A C C U G G U U G X  
CLS-
100:104 
G U C A G C U G G G A U X  
               
56 dpi               
Wild 
type 
C U C U C C U G G G A G X  
CLS-
105/106 
G U C A G C U G G G A U X  
CLS-
107 
G U C A G C U G G G A G X  
CLS-
108/109 
C U C U C C U G G G A U X  
CLS-
110:117 
C U C U C C U G G G A G X  
CLS-
118 
C U C U C C C U G G G G X  
CLS-
119 
G G A U C C U G G U U C X  
CLS-
120 
C C A A C C U G G G A G X  
CLS-
121 
C G G C A C U G G G A G X  
 
 
 59 
Second, all of the selected viruses were predicted by Mfold to form two nearly 
isoenergetic conformations of CGI, an extended form and a branched form (Figure 
24).  The extended CGI consisted of a continuous base pairing through the entirety of 
the C-box and G-boxes (Figure 24C).  The branched CGI consisted of a three way 
RNA junction with base pairing of the 5’ proximal C-box with the 3’ proximal G-
box, while the 5’ proximal G-box was base paired with the nucleotide 385 region, 
similar to a structure previously proposed (47) (Figure 24A & B).  The branched CGI 
was found in lowest energy structures for all but one of the viral sequences 
(Table 5). 
 
Figure 24.  Summary of the base pairing interactions involving the C-box and G-box found in the predicted 
optimal RNA structures from the co-randomized viral selection.   
(A) The most stable secondary structure predicted by Mfold for nucleotides 1-557 of the wild type HIV-2 
genomic RNA.  (B) and (C) When analyzed similarly, the 34 viral sequences from the evolved co-
randomized library (Table 5) grouped into two CGI conformations, the branched CGI (B) and the extended 
CGI (C).  Each potential base pairing interaction of the randomized nucleotides is shown.  Each ratio 
indicates the number of times this base pairing is found in the most stable CGI containing structure for 
each of the 34 viral sequences.  The double arrows indicate a level of flexibility with regard to the base 
pairing partner for the randomized nucleotide.  Depending on the identity of the randomized nucleotide, 
the base pairing partner in the designated region may shift by one or two positions. 
Selection for wild type sequence at the 5’ side of the proximal G-box (positions 540-
542) was readily apparent, represented by 15 out of 17 viruses on day 40 and 16 out 
of 17 viruses by day 56 (Table 5). 
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Although a significant percentage of viruses with wild type sequence emerged from 
our co-randomized library, it also produced CGI-forming viruses with non-wild type 
sequences (12 out of 17 sequences by day 40).  To determine whether these non-wild 
type viruses were viable, three late round viruses (CLS-119, CLS-120, and CLS-121) 
and one early round virus (CLS-005) were selected for individual testing to compare 
their viral replication to that of wild type (Figure 25).  To show that the C-box and G-
box mutations are solely responsible for the observed viral phenotypes, we cloned 
these mutations into the original wild type HIV-2 backbone.  All of the late round 
viruses were predicted to form the branched CGI while the CLS-005 was not.  As 
shown in Figure 25B, the early round CLS-005 displayed defective viral replication 
while late round CLS-119, CLS-120, and CLS-121 were replication competent when 
compared to wild type.  These results showed first that the CGI is important for viral 
replication and second that it can be studied outside of a wild type context. 
 
 
Figure 25.  Replication kinetics of mutant HIV-2 viruses. 
(A) Schematic of the five HIV-2 genomic RNAs produced in this study.  The CLS-119 RNA contains a 
mutated C-box and mutated G-box.  The CLS-120 RNA contains a mutated C-box and a wild type G-box.  
The CLS-121 RNA contains a mutated C-box and a wild type G-box.  The CLS-005 RNA contains a 
mutated C-box and a mutated G-box.  The mutations are in bold lowercase letters.  (B) Replication kinetics 
of wild type, CLS-119, CLS-120, CLS-121, and CLS-005 viruses in C8166 cells.  Equal amounts of viral 
particles (10 ng of p27 capsid, as determined by ELISA), produced during COS-7 transfection were used to 
infect C8166 cells.  Viral replication was measured using p27 capsid quantification.  The y-axis bars 
indicate standard error for two experiments. 
3.4.4	   Forced	  evolution	  of	  C-­‐box	  randomized	  viruses	  with	  a	  defective	  G-­‐box	  
To further evaluate the relationship of C-box and G-box sequences, we built a new 
randomized viral library that forced the viruses to compensate for a defective mutant 
G-box sequence with novel sequence combinations at the C-box.  Six nucleotides of 
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the C-box (nucleotides 194-199) were randomized using degenerate primers in an 
HIV-2 background containing a mutated G-box that is lethal by itself (Figure 26 and 
Figure 20).  
 
Figure 26.  Forced evolution library.   
Schematic of the C-box and G-box element in the forced evolution library.  Only the C-box and G-box 
regions of the unspliced genomic RNAs are represented.  Nucleotide positions containing an “N” have an 
equal probability of being A, C, G, or U.  The G-box mutation is in lowercase letters.  The Gag start codon, 
found in the G-box, is underlined. 
The proviral DNA library was transfected into COS-7 cells and the virions produced 
were used to infect C8166 cells.  Emergence of viable virus occurred after three 
weeks.  The mutated G-box sequence (5’541-CCACC) was conserved in all 
sequenced clones (data not shown).  All selected viruses contained guanosines at 
positions 194 and 195 of the C-box (Table 6).  There was more variability seen in 
position 196 although the wild type cytosine was completely absent in all selected 
viruses.  Wild type sequence (UCC) was found at positions 197-199 for most of the 
selected viruses, which would not be expected to base-pair with the mutated G-box 
nucleotides 540-542, located upstream of the gag AUG start codon.   
Table 6.  C-box sequences of viruses that were selected for in the forced evolution virus library following 
several rounds of infection in C8166 cells. 
Nucleotide at position:  
Time post 
infection 
and clone 
number 
194 195 196 197 198 199 
24 d.p.i       
Wild 
type 
C U C U C C 
CLS-143 G G A C G A 
CLS-132 G G A U G A 
CLS-130 G G G U C C 
CLS-131 G G G U C C 
CLS-140 G G G U C C 
CLS-142 G G U A A A 
CLS-133 G G U A C C 
CLS-151 G G U U C C 
CSL-153 G G U U C U 
CLS-161 G G U U C C 
CLS-162 G G U U C C 
CLS-163 G G U U C C 
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This experiment showed that mutations in the C-box rescued a lethal mutant G-box 
mutation.  Moreover, these results corroborated results from the co-randomized 
library, demonstrating selective pressure for base pairing between the 5’ proximal C-
box and 3’ proximal G-box. 
3.4.5	   Effects	  of	  artificially	  evolved	  C-­‐box	  and	  G-­‐box	  sequences	  on	  viral	  replication	  
Although the co-randomized and forced evolution library results supported a role in 
viral replication for the C-box and G-box through their base pairing interaction, our 
five and two nt mutational studies suggested that the sequence of each region may 
also have a CGI-independent role in viral replication.  To probe the individual roles 
of the C-box and G-box, a viral sequence (CLS-119) from the co-randomized library 
was selected for testing.  We chose CLS-119 for three reasons.  First, CLS-119 was a 
selected (viable) virus, predicted to form the branched CGI (Figure 24A & B).  
Second, the CLS-119 C- and G-boxes were non-native, composed equally of both 
wild type and non-wild type nucleotides (Table 5).  The CLS-119 C-box contained 
both purines (positions 194-196, GGA) and pyrimidines (positions 197-199, UCC) as 
did the G-box with mostly purines (positions 540-542, UGG) and pyrimidines 
(positions 543-545, UCC).  Third, although represented in the winning pool, CLS-119 
displayed delayed viral replication compared to the other selected viruses as well as 
wild type (Figure 25).  We therefore hypothesized that this delay may be a result of 
the individual contributions of the C-box and the G-box. 
To determine the individual effects of the non-native CLS-119 C-box and G-
box sequences, we built two additional clones and compared viral replication to that 
of wild type (Figure 27).   
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Figure 27. Mutant HIV-2 viruses. 
Schematic of the four HIV-2 genomic RNAs produced in this study.  The C-box119 RNA contains a 
mutated C-box and a wild type G-box.  The G-box119 RNA contains a wild type C-box and a mutated G-
box.  The CLS-119 RNA contains a mutated C-box and a mutated G-box.  The mutations are in bold 
lowercase letters. 
All of the clones were predicted to form the branched CGI, which allowed us to 
concentrate on individual effects of the C-box and G-box regions instead of effects of 
the CGI.  The CLS-119 clone contained both the mutated C- and G-boxes.  The C-
box119 and G-box119 clones contained either the CLS-119 C-box or the CLS-119 G-
box, respectively.  COS-7 cells were transfected with wild type, Cbox119, G-box119, 
and CLS-119 full-length HIV-2 plasmids.  Virions from the COS-7 supernatant were 
harvested and used to infect permissive C8166 cells.  Viral replication of the C-
box119 mutant, as determined by ELISA, reached wild type like levels, whereas the 
G-box119 and CLS-119 mutants exhibited attenuated replication (Figure 28).   
 
Figure 28.  Mutant HIV-2 viruses harboring G-box mutations display attenuated replication. 
Replication kinetics of wild type, C-box119, G-box119, and CLS-119 viruses in C8166 cells.  Equal amounts 
of viral particles (10 ng of p27 capsid, as determined by ELISA), produced during COS-7 transfection, were 
used to infect C8166 cells.  Viral replication was measured using p27 quantification.  The y-axis error bars 
indicate standard error for two experiments. 
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The shared feature of the G-box119 and CLS-119 mutants is the presence of the 
mutated G-box.  To determine whether the decrease in replication was a result of a 
packaging deficiency linked to the presence of the G-box, intracellular and virion 
RNA levels were examined. 
We measured intracellular viral RNA levels and virion RNA content using an 
RNase protection assay (RPA) (Figure 29).  Intracellular gag RNA levels were very 
similar, while RNA levels found in the virion fractions differed (Figure 29).  
Surprisingly, the C-box119 virus had higher levels of genomic RNA encapsidated 
(normalized to extracellular capsid protein p27) than the other viruses.  This 
suggested that in addition to affecting dimerization, translation, and 5’UTR splicing, 
the C-box also plays a role in encapsidation.   
 
 
Figure 29.  C-box mutation results in increased RNA encapsidation. 
(A) A schematic of the radioactive probe and predicted protected fragments based on the presence of a wild 
type or mutant G-box.  (B) RNase protection assay of intracellular RNAs obtained from duplicate 
experiments.  DNA templates used for each transfection are listed below each lane (lanes 1-8).  Lanes 9 and 
10 contain yeast RNA used as a non-specific target control, incubated with or without RNases, respectively.  
(C) RNase protection assay of virion RNAs produced from duplicate HIV-2 DNA transfected COS-7 cell 
experiments.  DNA templates used for each transfection are listed below each land (lanes 1-8).  (D) 
Quantification of (B) and (C).  RNA levels were normalized to wild type levels, set at 100% for both 
intracellular and virion samples.  Identities of RNA source, intracellular or virion, and DNA templates used 
for each transfection are listed on the x-axis.  The y-axis represents gag and gag-pol RNA levels in percent.  
The y-axis error bars indicate standard error for the two experiments. 
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However, the RPA results could not explain why the presence of the G-box resulted 
in decreased replication.  Because the mutated G-box encompasses the Kozak 
sequence of the gag initiation site, we hypothesized that perhaps this mutation altered 
the translation of gag mRNA.  Therefore, we then sought to determine if the 
attenuated viral replication seen with the G-box119 and CLS-119 viruses was the 
result of decreased translational efficiency.  To that end, we examined both 
intracellular and virion fractions of transfected COS-7 cells for total Gag levels 
(Figure 30).  The intracellular and virion protein fractions were examined via western 
blotting, using a primary antibody against p27 capsid.  Both the CLS-119 and G-
box119 viruses showed a marked decrease in total Gag levels both inside and outside 
the cell compared to C-box119 and wild type viruses (Figure 30C and D).  In addition 
to differences in total Gag levels, there were also differences in the relative 
expression of three isoforms of Gag between viruses with a mutant G-box and those 
with a wild type G-box.  Ohlmann and coworkers have shown that these three 
isoforms of Gag are expressed during HIV-2 infection, which they attributed to 
alternative initiation events (96,99).  The first isoform, p58, initiates synthesis form a 
start codon located at nucleotides 546-548 (AUG1).  The second isoform, p51, 
initiates from a start codon located at positions 744-746 (AUG2).  The third isoform, 
p45, initiates synthesis from a start codon located at positions 897-899 (AUG3).  
Interestingly, clones containing the mutant G-box, i.e., G-box119 and CLS-119, 
exhibited an increased level of the p45 Gag isoform initiated from AUG3 compared 
to wild type and to the C-box119 mutant (Figure 30C; compare lanes 2-5 with lanes 
6-9). 
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Figure 30.  Effects of a mutated G-box on Gag production in cell culture. 
(A) A schematic of the four HIV-2 genomic RNAs produced in this study.  The mutations are in bold 
lowercase letters.  (B) A schematic of the three HIV-2 Gag protein isoforms that are synthesized in cell 
culture.  The 58, 51, and 45 kDa isoforms are synthesized when translation initiates from methionine codons 
at positions 546, 744, and 897, respectively.  (C) Western blot analysis of intracellular proteins from 
duplicate experiments where COS-7 cells were transfected with equimolar amounts of the wild type, C-
box119, G-box119, or CLS-119 proviral DNAs.  Lane 1 contains the mock-transfected sample.  DNA 
templates used in each transfection are designated below each lane.  The relative proportion of each isoform 
band was quantified and is graphically represented.  The y-axis error bars represent the standard error of 
duplicate experiments.  (D) Western blot analysis of virion proteins produced from duplicate experiments 
where COS-7 cells were transfected with equimolar amounts of the wild type, C-box119, G-box119, or CLS-
119 proviral DNAs.  DNA templates used in each transfection are designated below each lane.  The 
averaged level of capsid p27 protein in the COS-7 media was quantified (ELISA) and is indicated below the 
western blot.  The relative proportion of each isoform band was quantified and is graphically represented.  
The y-axis error bars represent the standard error of the duplicate experiments. 
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3.4.6	   In	  vitro	  translation	  of	  luciferase	  RNAs	  containing	  mutated	  C-­‐box,	  G-­‐box,	  or	  
both	  
To test whether the different levels of Gag isoforms seen in clones containing the 
mutant G-box were caused by altered start codon usage, we assayed the translation of 
the HIV-2 C-box and G-box mutant constructs in an in vitro rabbit reticulocyte 
translation assay.  As shown in Figure 31, constructs containing a mutated G-box 
demonstrated differences in gag start codon usage compared to constructs with a wild 
type G-box.  Both CLS-119 and G-box119 gag-luciferase constructs demonstrated a 
slight increase in usage of the AUG3 start codon, similar to what was seen in cell 
culture.  These data suggest that the different levels of the isoforms are caused by 
altered start codon usage, and that this difference is directly influenced by the 
mutation in the G-box. 
 
 
Figure 31.   In vitro translation of luciferase mRNAs harboring mutated HIV-2 5’ leaders. 
(A) A schematic of the four mRNA constructs used in S35 in vitro translation assays.  The mutated 
nucleotides are in bold lowercase letters.  (B) A schematic of the three HIV-2 Gag-luciferase fusion protein 
isoforms that are synthesized in vitro.  The 50, 42, and 37 kDa isoforms are synthesized when translation 
initiates from methionine codons located at positions 546, 744, and 897, respectively.  (C) Duplicate S35 in 
vitro translation assays of the wild type, C-box119, G-box119, and CLS-119 mRNAs.  Lane 1 contains a 
mock where no mRNA was added to the translation reaction.  RNAs used in each translation reaction are 
indicated below each lane.  (D) Quantification of protein isoform expression levels.  The RNAs used are 
indicated on the x-axis, along with the protein isoforms produced and quantified.  The level of protein 
isoforms in arbitrary units is indicated on the y-axis.  The y-axis error bars represent the standard error of 
the duplicate experiments.  
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3.5	   Discussion	  
In this study, we employed viral SELEX to determine the role of the CGI in viral 
replication.  Generating a collection of unique viruses that differed only in their C-
box and G-box regions allowed us to circumvent the experimental limitations of 
building and testing one unique mutant at a time.  Testing these viruses in a 
competitive cell culture setting allowed us to examine in detail viable viruses with 
CGI sequence combinations not found in nature.  Our results using this viral 
evolution technique emphasize the importance of the CGI for viral replication and 
fine-tune our understanding of base pairing arrangements in this region.  Furthermore, 
we show that in addition to a CGI-dependent role, the C-box and G-box have CGI-
independent roles in viral replication. 
We demonstrate here that mutation of the C-box affects HIV-2 encapsidation 
levels (Figure 29), suggesting a role for the C-box in the packaging process.  
Mutation of the C-box may contribute to encapsidation through structural 
rearrangements of the 5’UTR, exposing previously hidden motifs while trapping 
others (135).  Indeed, in HIV-2, destabilization of the CGI was shown to free RNA 
elements essential for dimerization (SL1) and encapsidation (Ψ) from structural 
entrapment (54).  Another possibility is that the enhanced encapsidation phenotype 
may be due to enhanced binding of nucleocapsid protein (NC) to the mutated C-box.  
It is known that NC mediates genomic RNA encapsidation by binding RNA elements 
found in the 5’ leader region (136,137).  Studies of HIV-1 leader RNA have 
suggested a role for the C-box as a binding partner of NC, wherein the binding of NC 
disrupts the CGI (138,139).  Additionally, in vitro HIV-1 mutant RNAs harboring 
guanosines in the C-box displayed enhanced NC binding affinity compared to wild 
type (138).  Here, the mutated CLS-119 C-box differs from the wild type C-box at the 
5’ proximal positions 194-196, with the sequence GGA instead of CUC.  It is possible 
that the presence of two non-wild type guanosines in the mutant C-box may influence 
NC binding and encapsidation in HIV-2.  It is conceivable that wild type C-box 
functions as a good but not ideal encapsidation enhancer, similar to what we have 
shown for the G-box and its modulation of translation.  However, we cannot rule out 
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an indirect effect of the CLS-119 C-box mutation on the presentation of RNA signals 
such as encapsidation elements. 
Our studies on the G-box demonstrated the extreme sensitivity of this region 
to mutation.  Besides its CGI-dependent context, the G-box sequence is also 
constrained by the basic requirement for a start codon and an adjacent glycine codon 
to serve as the myristoylation signal (140).  In addition, G-box nucleotides are 
involved in translation initiation as part of the Kozak sequence.  It is notable that 
according to the Kozak consensus rules, the context of the wild type start codon 
AUG1 is good but not ideal (78).  Interestingly, when we mutated the G-box 
sequence closer to an ideal consensus sequence, resulting mutant viruses were not 
viable.  This suggested that enhancement of AUG1 translational efficiency is not 
necessarily beneficial in the overall scheme of HIV-2 viral replication.  Conversely, 
we show that viruses displaying decreased AUG1 translational efficiency compared 
to wild type, are viable (Figure 28) but display altered ratios of the three isoforms of 
Gag.  The decrease in p58 Gag production is expected due to the mutation of the 
AUG1 Kozak consensus sequence, however the slight increase in p45 Gag production 
(AUG3 initiation) is notable.  The p45 Gag isoform was previously shown to be 
necessary for efficient viral replication, but its role remains obscure (96). 
Previous studies on HIV-2 translation have suggested that the genomic RNA 
contains an IRES located downstream of the gag AUG1 initiation codon (96,99).  The 
HIV-2 IRES recruits ribosomes for translational initiation at AUG1 and downstream 
counterparts AUG2 and AUG3, generating the three Gag isoforms.  IRES initiation at 
each of the three AUGs occurs independently of one another (98).  Interestingly, we 
observed that mutation of nucleotides immediately upstream of AUG1 resulted in 
altered Gag isoform ratios.  Although it is possible that the three nucleotide G-box 
mutation affected the IRES-dependent gag initiations, a more likely scenario is leaky 
scanning at the AUG1.  It has been recently shown that initiation at the HIV-1 AUG1 
gag initiation site primarily occurs through ribosomal scanning (92).  Since our HIV-
2 G-box mutation results in a weaker Kozak context for AUG1, leaky scanning at this 
initiation site enhances the use of a least one of the downstream start codons.  Indeed, 
leaky scanning is a common mechanism used in HIV-1 translation.  Several 
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laboratories have shown that the strength of upstream AUGs can influence initiation 
at downstream AUGs (141-143).  Mutation of a weak upstream HIV-1 rev Kozak 
sequence to a strong initiating sequence resulted in decreased leaky scanning and 
poor initiation at the downstream vpu AUG (142).  Alternately, here the CLS-119 
AUG1 mutation is a relatively poor Kozak context compared to the wild type AUG1, 
resulting in increased initiation at the downstream AUG3.  Of the three potential gag 
initiation codons in CLS-119, AUG3 is predicted to have the best Kozak context, thus 
a scanning ribosome could scan past AUG1 and 2 and initiate translation at AUG3 
more often than when the Kozak context of AUG1 is wild type (78,81).  Taken 
together, we propose that the strength of the Kozak context sequence for the HIV-2 
gag AUG1 start codon is evolutionarily fine-tuned to allow balanced synthesis of Gag 
isoforms and that, in combination with the C-box, there could be a higher order 
structure component to the use of the AUG1 start codon as well. 
The main focus for this study was to determine the necessity of the CGI in 
HIV-2 replication.  Our viral SELEX work supports a role for the association of the 
C-box with the G-box with the caveat that both local and long distance constraints 
govern the CGI.  Local sequence constraints limit nucleotide identity in both the C-
box and G-box.  Sequence identities in these regions appear to affect 5’UTR splicing, 
Gag or NC binding, and the Kozak consensus sequence.  However, our co-
randomization and forced evolution experiments demonstrated reproducibly that 
partial base pairing across this region is necessary, as seen in the branched CGI 
conformation (Figure 24A & B).  Indeed, the forced evolution experiment clearly 
illustrates that a relationship between the C-box and G-box exists in HIV-2 
replication.  A lethal viral replication phenotype associated with the presence of the 
mutant G-box (CCACC) was rescued by the presence of the selected C-boxes.  The 
selected C-boxes in this library all contain guanosines at positions 194 and 195, 
which are compatible for base pairing with the mutant G-box cytosines at positions 
544 and 545.  Interestingly, extension of the CGI through additional base pairing did 
not emerge significantly among non-wild type surviving viruses from both the forced 
evolution and co-randomized libraries.  Instead, it seems that selective pressure may 
be exerted at these remaining positions (197-199) to keep the CGI from becoming too 
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stable and to allow the 5’ proximal G-box to form a long distance base pairing 
interaction with the nucleotide 385 region.  In all sequences forming the branched 
CGI, nucleotides 200-204 (just downstream of the randomized C-box) were base-
paired with nucleotides 379-376, irrespective of the identity of randomized 
nucleotides 197-199.  It is notable that the base pairing interaction of the 5’ proximal 
G-box with the nucleotide 385 region could vary through shifting of one or two 
nucleotides depending on the identity of the randomized G-box nucleotides. 
Our two-and five-nucleotide mutations experiments support the pressure for 
CGI flexibility, as we saw that high stability base pairing across the entire mutated 
CGI results in a lethal phenotype.  The replication-defective two-nucleotide double 
mutant is predicted to be unable to form two of the three branches of the branched 
CGI.  Similarly, the five-nucleotide double mutant is also predicted to be unable to 
form two of the three branches of the branched CGI.  Only when the five-nucleotide 
G-box was paired with a randomized C-box that did not extend base pairing through 
the CGI, were viable viruses obtained.  Furthermore, analysis of published HIV-
2/SIV sequences (144) shows several examples of nucleotide variations that maintain 
base pairing that is consistent with our “artificial phylogeny” and supports a branched 
three-way RNA junction (Figure 32).   
 
 
Figure 32.  Nucleotide identities of non-conserved position among natural isolates of HIV-2 and SIV 
superimposed on the two potential CGI conformations.   
The consensus branched (A) and extended (B) CGI structures from the analysis of 42 HIV-2 and SIV 
sequences from the HIV Sequence Compendium 2010 is indicated, with the proportions of alternative base 
pairs shown (144).  Those nucleotides not absolutely conserved are boxed. 
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In particular, a key element in the branching CGI structure is the base pairing of some 
of the G-box nucleotides with the 385 region.   These four base pairs are highly 
conserved, which is further illustrated by a conservative compensatory mutation in 
the isolate SIVsmmSL92. 
Our data emphasize the importance of the CGI in vivo and suggest a model in 
which some degree of CGI association is necessary, as seen in the branched model 
(Figure 24A & B) (47), but because of roles in multiple steps of the HIV-2 replication 
cycle, the CGI needs to be dynamic.  The dynamic nature of base pairing in the 5’ 
leader has previously been supported in the context of the LDI/BMH riboswitch 
affecting the BMH and LDI conformational equilibrium in HIV-1 RNA (53).  
Although it has been shown that the base pairing between the C-box and G-box in 
mature HIV-1 particles is maintained in the open conformation (139), its behavior in 
HIV-2 still needs to be investigated.  Mapping the dynamic range of the CGI during 
select replication steps would provide further insight into the CGI’s mode of action. 
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CHAPTER	  FOUR:	  	  DISCUSSION	  
4.1	   Summary	  of	  work	  
The 5’UTR intron and the CGI are two elements within the 5’UTR that regulate 
multiple steps in HIV-2 replication.  When the 5’UTR intron is removed or the base 
pairing partners in the CGI are mutated, HIV-2 gag/gag-pol translation, 
encapsidation, and Gag isoform ratios are altered.  
We have shown that 5’UTR splicing of gag and gag-pol RNA species occurs 
in vitro (i.e., in cell culture) and in vivo (from samples obtained from asymptomatic 
HIV-2 infected patients) (131).  The removal of secondary structure by 5’UTR 
splicing results in specialized isoforms of gag/gag-pol RNAs that display increased 
translational efficiency compared to their unspliced counterparts (131).  In addition to 
removing local secondary structures such as the poly (A) signal domain, 5’UTR 
splicing also disrupts a long-range base-pairing interaction, the CGI. 
The C-box is involved in a long-range base-pairing interaction with the G-
box, termed the CGI.  The CGI is disrupted by 5’UTR splicing because the C-box is 
positioned within the 5’UTR intron and encompasses the poly-pyrimidine tract of the 
5’UTR splice acceptor site.  Disruption of the CGI was predicted to enhance 
translational efficiency by eliminating potentially inhibitory base pairing of the gag 
start codon.  In vitro translation studies demonstrated that disruption of the CGI by 
deletion or mutation of the C-box did result in increased translational efficiency 
(131).  Additional studies to determine the base pairing and nucleotide identity 
requirements of the CGI were performed using viral SELEX. 
A branched CGI was selected for in the HIV-2 randomized viral SELEX 
experiments (Figure 33).  In addition to identifying this novel secondary structure in 
HIV-2, additional roles for the C-box and G-box were uncovered.  Our CLS-119 
studies illustrated that mutating the C-box can result in enhanced genomic RNA 
encapsidation while mutating the G-box can lead to decreased viral replication and 
altered Gag isoform ratios.  In essence, we have demonstrated a role for the CGI in 
encapsidation and in translation. 
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Figure 33.  The branched HIV-2 CGI. 
The structure of the HIV-2 CGI is supported by observed patterns of base pairing arrangements that 
dominated after randomization of this region and selection for viable viruses. The gag initiation codon is 
underlined.  
4.2	   Retroviral	  RNA	  translation	  and	  encapsidation	  
Multiple RNA species are generated during the HIV replication cycle.  In HIV-1, the 
47 unique RNA species produced are assigned to three classes based on size (107).  
The RNA classes include 1.8 kilobases, 4.0 kilobases, and 9.0 kilobases (Figure 34). 
All HIV-1 RNA classes except for one contain multiple members.  The 9.0 kb class 
contains only one RNA species, the unspliced gag-pol RNA.  The unspliced gag-pol 
RNA (i.e. the genomic RNA) is unique among the HIV-1 RNA species because it 
contains the complete encapsidation signal.  All other HIV-1 RNAs do not contain the 
encapsidation signal because this element is located downstream of the major splice 
donor site and is thus removed during splicing of the 1.8 and 4.0 kb classes.  
Therefore, only the full-length genomic RNA is encapsidated based on the presence 
of the primary encapsidation signal.  This is not the case in HIV-2. 
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Figure 34.  HIV-1 RNA species. 
A representation of the viral RNA species generated during HIV-1 replication.  The viral RNAs are 
grouped into size classes including 9.0 kb, 1.8 kb, and 4.0 kb.  The splice acceptor sites used are indicated 
above the sample viral RNA while the splice donor sites are found below.  A white box represents the 
encapsidation signal.  Adapted from (107). 
In HIV-2, the primary encapsidation signal, ψ, is located upstream of the 
major splice donor site.  Thus, all HIV-2 RNA species contain this part of the 
apparently multipartite encapsidation signal.  To complicate matters, there are twice 
as many RNA species in HIV-2 than in HIV-1.  The doubling of RNA species results 
from 5’UTR splicing so instead of approximately 47 unique RNAs, there are now 
approximately 94 unique RNAs.  Although all HIV-2 RNAs contain ψ, only the 
genomic RNA is encapsidated (115).  The selectivity of the encapsidation is based on 
a cotranslational encapsidation mechanism.  The genomic HIV-2 RNA is first 
translated, producing Gag/Gag-Pol proteins.  Once synthesized, the Gag/Gag-Pol 
proteins bind preferentially, through their nucleocapsid domains, to the encapsidation 
signal of the translated genomic RNA (115).  Hence, multiply spliced HIV-2 RNAs 
are not encapsidated because they do not produce Gag.  However, the cotranslational 
mechanism does not explain why 5’UTR spliced gag-pol RNAs are not encapsidated.   
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Both 5’UTR unspliced and spliced gag-pol RNAs produce Gag and Gag-Pol 
proteins (131).  Both gag-pol RNA species contain the primary encapsidation signal.  
Yet, 5’UTR spliced gag-pol RNAs are not encapsidated to detectable levels (131).  
So, how does HIV-2 preferentially encapsidate unspliced gag-pol RNAs over 5’UTR 
spliced gag-pol RNAs?  A closer examination of both RNA species sequences reveals 
a key difference between the two that may influence encapsidation.  The 5’UTR 
spliced gag-pol RNA lacks the C-box.  As was shown in Chapter 3, the sequence 
identity of the C-box plays a role in encapsidation.  Indeed, the C-box (by way of the 
CGI) forms a novel secondary structure that more than likely also affects the 
presentation of the primary encapsidation signal.  Based on the results in Chapters 2 
and 3, one could hypothesize that 5’UTR spliced gag-pol RNAs are not encapsidated 
because of the absence of the C-box and therefore the CGI.  Instead these specialized 
RNAs are used to produce large quantities of Gag and Gag-Pol proteins.  These 
proteins are then used in virion construction and encapsidation of unspliced gag-pol 
RNAs.  This seems likely based on previous encapsidation studies by the Lever 
laboratory.  Their studies demonstrated that Gag proteins produced by encapsidation-
defective gag-pol HIV-2 RNAs were used in trans to encapsidate wild-type gag-pol 
RNAs (119).  This seems the mechanism likely to be employed by HIV-2 when 
5’UTR splicing is activated.  To fully appreciate these dynamics during HIV-2 
replication, a closer examination of 5’UTR splicing and the CGI is warranted.  
4.2.1	   The	  role	  of	  5’UTR	  splicing	  in	  gag/gag-­‐pol	  RNA	  translation	  
In retroviruses, Gag and Gag-Pol were previously thought to only be synthesized 
from the unspliced genomic RNA (130).  Although this criterion was applied to all 
retroviruses, genomic RNA encapsidation differences were identified and resulted in 
the proposal of more than one model of retroviral encapsidation (130).  The main 
models at the time differed as to whether or not two pools of unspliced gag/gag-pol 
RNAs existed in the cytoplasm (Figure 35).  In model 1, two pools of unspliced 
gag/gag-pol RNAs exist in the cytoplasm, one designated for translation and the other 
for encapsidation.  This model is supported by research on murine leukemia virus 
(MLV) encapsidation (145,146).  In model 2, there is only one pool of unspliced 
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gag/gag-pol RNAs, which is translated before encapsidation.  Model 2 is supported 
by research on HIV-1 and SIVcpz  encapsidation (145,146).  Unlike HIV-1 and SIVcpz, 
HIV-2 and SIVmac239 encapsidation do not exactly fit either model.  Instead, the 
identification of 5’UTR splicing in both HIV-2 (131) and SIVmac239 (109) suggested 
an alternate mechanism of regulating translation and encapsidation.  The alternate 
mechanism called for a third model, which was proposed in Chapter 2.  In model 3, 
there are two pools of gag/gag-pol RNAs, similar to what is seen in model 1 (Figure 
35).  However, unlike model 1, the two RNA pools differ based on the presence of 
the 5’UTR intron.  In model 3, there is a RNA pool specialized for translation in 
which the 5’UTR intron has been removed.  The other RNA pool contains unspliced 
gag/gag-pol RNAs that undergo translation and encapsidation, similar to model 2 
(131).  As discussed above, 5’UTR splicing plays an indirect role in HIV-2 
encapsidation.  However, how 5’UTR splicing correlates to the overall cycle of HIV-
2 infection in patients requires further analysis. 
 
Figure 35.  Models of translation and encapsidation of retrovirus gag/gag-pol RNAs. 
In model 1, two pools of unspliced gag/gag-pol RNAs exist.  The first pool is designated for translation-only.  
The second pool is designated for packaging-only.  In model 2, one pool of unspliced gag/gag-pol RNAs 
exists.  The unspliced gag/gag-pol RNAs are translated prior to packaging.  In model 3, two pools of 
gag/gag-pol RNAs exist.  The first pool is composed of gag/gag-pol RNAs that have undergone 5’UTR 
splicing.  The 5’UTR spliced gag/gag-pol RNAs are specialized for translation.  The second pool is 
composed of unspliced gag/gag-pol RNAs that are translated prior to encapsidation.  Adapted from (130) 
and (131). 
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Results presented in Chapter 2 show that the 5’UTR spliced gag/gag-pol RNAs exist 
in asymptomatic HIV-2 infected patient samples.   In cell culture and in vitro, the 
5’UTR-spliced gag/gag-pol RNAs are specialized for Gag/Gag-Pol synthesis (131).  
Based on these 5’UTR splicing results, one might hypothesize that a balanced 
increase in translation of HIV-2 proteins through 5’UTR splicing may lead to an 
increase in virion production.  Initially, increasing virion production may help to 
establish a persistent HIV-2 infection in vivo.  In the long term, this increased virion 
production would lead to progression of HIV-2 infection to AIDS.  To test this 
hypothesis, cell culture and animal model studies could be employed.  Experiments 
designed to characterize 5’UTR splicing using PBMCs and a mouse model system are 
described below. 
Experiment 1:  Characterize 5’UTR splicing in PBMCs.    
In Chapter 2, PBMCs of asymptomatic HIV-2 infected individuals were analyzed for 
the presence of 5’UTR spliced gag/gag-pol RNAs.  Two of the five asymptomatic 
patient samples contained 5’UTR-spliced gag/gag-pol RNAs.  At this time, analysis 
of 5’UTR splicing in symptomatic HIV-2 infected patient samples has not been 
performed.  Because 5’UTR splicing may contribute to a surge in overall HIV 
replication, one might expect to see 5’UTR splicing occurring in the majority of 
PBMC samples of symptomatic HIV-2-infected individuals.  Therefore, using RT-
PCR to determine the presence/absence of 5’UTR splicing within the HIV-2 viral 
gag/gag-pol RNA populations of PBMC samples of symptomatic HIV-2 infected 
individuals would establish (or not) the correlation of prevalence of 5’UTR splicing 
and the transition to a symptomatic stage.  In addition, two primary HIV-2 replication 
studies in PBMCs could provide further insight into the role of 5’UTR splicing in 
HIV-2 replication.  The first would compare the viral replication kinetics of wild type 
and SD (-) in PBMCs.  The second would determine viral fitness through competition 
experiments.  Various ratios of wild type and SD(-) would be used to jointly infect 
PBMCs and each competition would be followed to determine the dominant virus.  
Viral replication kinetics of the viruses would be compared using ELISA, reverse 
transcriptase assays, RT-PCR, RPA and Western blot. 
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Experiment 2:  Determining the role of HIV-2 5’UTR splicing using a mouse 
model system.   
To elucidate how 5’UTR splicing functions during a bona fide HIV infection, an 
animal model could be used.  Previous research has shown that the genetically 
modified Rag2-/-γc-/-(Rag-hu) mice are capable of maintaining multi-lineage human 
hematopoiesis.  The human T-cells produced by the Rag-hu mice are targets and 
therefore susceptible to HIV infection (147).  Moreover, the mice can mount an 
immune response and maintain chronic HIV infection with continued CD4 T-cell 
depletion (148).  Using this animal model would allow one to examine the role of 
5’UTR splicing in early, mid-, and late HIV-2 infection.  To test the role of 5’UTR 
splicing during a bona fide HIV-2 infection, mice will be infected with either HIV-2 
wild-type or 5’UTR SD(-) viruses.  HIV-2 infection will be followed over time and 
compared for both mice series using RNA in situ hybridization, CD4 T-cell depletion 
assays, PCR, and RT-PCR. 
4.2.2	   The	  role	  of	  the	  CGI	  in	  genomic	  RNA	  encapsidation	  
The CGI in HIV-1 is found in a structure that is capable of dimerization (53), 
suggesting a positive role in dimer formation.  Although associated with dimer 
formation, the HIV-1 CGI is not found in mature virions.  Instead, in the mature 
virion, the HIV-1 C-box interacts with nucleocapsid protein (139).  In contrast to 
HIV-1, the CGI in HIV-2 is associated with inhibition of dimerization (47).  
Formation of the HIV-2 CGI is thought to result in structural entrapment of 
dimerization (SL1) and encapsidation (Ψ) signals (54).  Interestingly, addition of 
nucleocapsid protein can relieve this inhibition in HIV-2 (47).  Unfortunately, unlike 
HIV-1, there are no studies probing the CGI in HIV-2 mature virions.  In spite of this, 
studies suggest a role for the C-box in HIV-2 encapsidation. 
Studies described in Chapter 3 demonstrated that some mutations within the 
C-box result in a gain of function, i.e. enhanced genomic encapsidation.  Why the C-
box mutations resulted in enhanced encapsidation has not been definitively 
determined.  Perhaps enhanced binding of nucleocapsid to the mutated HIV-2 C-box 
results in the enhanced encapsidation phenotype.  The presence of guanosines within 
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the C-box of HIV-1 is associated with enhanced NC binding (138), which suggests 
that the guanosine mutations in the C-box119 virus may also enhance NC binding.  A 
caveat to this is that whether this gain of function confers increased viral fitness 
during viral competition has not been determined.  Further studies are needed to 
elucidate the fitness of the enhanced encapsidation phenotype and the mechanism 
behind the gain of function.  A set of potential experiments to address this is 
described below. 
Experiment 1:  Determine the role of the C-box in NC binding and fitness.  
Mutation of the three nucleotides at positions 194-196 (CUC to GGA) in the C-box 
resulted in increased genomic HIV-2 encapsidation.  The presence of guanosines in 
the HIV-1 C-box has been shown to be associated with increased NC binding (138).  
Therefore a comparison of the Gag/NC binding affinities of C-box119 to HIV-2 wild 
type could be performed.  This would determine if the presence of guanosines in the 
C-box is associated with increased Gag/NC binding.  In addition, an examination of 
whether the C-box119 gain of function contributes to overall fitness of the mutant 
virus during replication is worthwhile.  This would entail performing competition cell 
culture studies using various ratios of C-box119 and HIV-2 wild type viruses.  C8166 
cells would be jointly infected with varying ratios of the two viruses and each 
competition would be followed until dominance of one virus occurred. 
4.2.3	   A	  HIV-­‐2	  model	  linking	  translation,	  dimerization,	  and	  encapsidation	  
Based on the results described in Chapters 2 and 3, a model that links translation, 
dimerization, and encapsidation can be proposed for HIV-2.  Key elements of this 
model include 5’UTR splicing, nucleocapsid binding, and formation and disruption of 
the CGI.  The first step in the model involves the role of 5’UTR splicing in 
translation. 
5’UTR spliced gag and gag-pol RNAs display high levels of translational 
efficiency resulting in faster accumulation of Gag and Gag-Pol (Figure 36).  
Translation that produces more Gag and Gag-Pol equates to more nucleocapsid 
because it is a component of these poly-proteins.  Because the 5’ UTR spliced gag-
pol RNAs lack the CGI, the genomic RNA pool uses the proteins synthesized.  A 
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larger population of Gag and Gag-Pol would increase the probability of the binding of 
nucleocapsid domain to the C-box of the genomic RNAs during translation. The 
binding event would prevent the C-box from base pairing with the G-box.  If the CGI 
does not form in HIV-2, SL1 and ψ will no longer be masked through a forced base 
pairing interaction.  SL1 would be free to initiate dimerization and ψ would be 
available to initiate encapsidation.  Thus, the increased translational efficiency from 
5’UTR splicing would negatively affect the formation of the CGI, resulting in 
dimerization and encapsidation of the genomic RNA (Figure 36). 
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Figure 36.  Coupling translation, dimerization and encapsidation in HIV-2. 
The 5’UTR spliced gag RNA is shown in red.  The 5’UTR unspliced genomic RNA is shown in blue.  Gag 
proteins translated from the 5’UTR spliced RNA or unspliced genomic RNA are represented by red ovals 
or blue ovals, respectively.  Base pairing interactions between elements are shown in black.  Scanning and 
translating ribosomes disrupt the CGI.  Accumulation of Gag proteins synthesized from 5’UTR spliced 
RNAs leads to binding of Gag to the C-box of the genomic RNA, preventing reformation of the CGI.  Gag 
proteins synthesized from the unspliced genomic RNA can now bind to the displayed packaging signal.  The 
SL1 element of the genomic RNA cannot interact with the SL1 element in another genomic RNA.  
Dimerization and packaging follow. 
4.3	   Implications	  of	  current	  work	  
The research described in Chapters 2 and 3 provides insight into mechanisms 
regulating several steps of the HIV replication cycle.  These mechanisms include 
5’UTR splicing and CGI formation/disruption.  We have shown that 5’UTR splicing 
regulates translational efficiency of HIV-2 gag/gag-pol RNAs.  We have also shown 
that the C-box and G-box have individual and cooperative roles in the viral cycle.  
Based on this research, the C-box and G-box are strong candidates for anti-retroviral 
targeting design. 
Both the C-box and G-box are highly conserved RNA motifs in HIV-1 and 
HIV-2.  In addition, these RNA motifs have been shown to regulate multiple steps of 
the HIV replication cycle.  The C-box was shown to regulate encapsidation, 5’UTR 
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splicing, CGI formation, and translation in HIV-2.  The G-box was shown to regulate 
HIV-2 Gag translation, Gag isoform ratios, and CGI formation.  Because of their high 
level of sequence conservation and multiple roles in HIV replication, the C-box and 
G-box would be worthwhile targets for anti-retroviral drug design.  By targeting just 
one motif, an effective drug could potentially affect the individual and collective 
role(s) of the motif and therefore may affect multiple steps of the viral replication 
cycle simultaneously. 
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